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The placenta mediates fetal growth by acting as a substrate for nutrient 
exchange between the mother and the fetus. Environmental factors such as altitude 
have been shown to result in reduced maternal-fetal exchange leading to reduced birth 
weight. To determine if differences in gene expression maybe contributing to 
physiological differences between individuals at high and low altitude, we tested for 
differences in gene expression and DNA methylation between Andean and European 
placental samples from La Paz (~4,000m) and Santa Cruz, Bolivia (~400m). Among the 
ancestry-associated differentially expressed genes, were genes involved in 
inflammation and placental specific pro-angiogenic macrophages, Hofbauer cells, 
contributing to increased capillary growth seen among Andeans residing at high altitude. 
Among the altitude-associated differentially expressed genes, we saw decreased 
expression of genes associated with the activator protein 1 (AP-1) transcription factor 
pathway and increased expression of genes involved in cytotrophoblast fusion including 
the gene dysferlin (DYSF). Upon closer examination we noticed that DYSF had a 
variant (rs10166384;G/A) at a methylation site with 3 levels of DNA methylation 
corresponding to individual genotypes. We tested for natural selection by sequencing a 
~2.5kb fragment from 90 samples and performing Tajima’s D test across the sample 
groups. We found that balancing selection (Tajima’s D=2.37) was acting on a ~2.5kb 
fragment around our variant of interest among Andeans regardless of altitude. This 
suggests that balancing selection acting on dysferlin maybe altering DNA methylation 
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CHAPTER 1: A REVIEW OF INTER- AND INTRA-SPECIFIC VARIATION IN THE 
EUTHERIAN PLACENTA 
Abstract: 
The placenta is one of the most morphologically variable mammalian organs. 
Four major characteristics are typically discussed when comparing the placentas of 
different eutherian species: placental shape, maternal-fetal interdigitation, intimacy of 
the maternal-fetal interface, and the pattern of maternal-fetal blood flow. Here we 
describe the evolution of three of these features as well as other key aspects of 
eutherian placentation. In addition to inter-specific anatomical variation, there is also 
variation in placental anatomy and function within a single species. Much of this intra-
specific variation occurs in response to different environmental conditions such as 
altitude and poor maternal nutrition. Examinations of variation in the placenta from both 
intra- and inter-species perspectives elucidate different aspects of placental function 
and dysfunction at the maternal-fetal interface. Comparisons within species identify 
candidate mechanisms that are activated in response to environmental stressors 
ultimately contributing to the etiology of obstetrical syndromes such as preeclampsia. 
Comparisons above the species level identify the evolutionary lineages on which the 
potential for the development of obstetrical syndromes emerged.  





1Published as : Gundling W.E. Jr., Wildman D.E.  A review of inter- and intra- specific 
variation in the eutherian placenta, Philosophical Transactions of the Royal Society B, 








The placenta is the conduit between the mother and fetus and directs fetal growth and 
development by acting as a source of nutrient exchange (1). The placenta mediates the 
transfer of nutrients including oxygen, amino acids, lipids, and glucose from the mother 
to the fetus and provides a method for fetal waste excretion by way of the mother (2). 
While these functions are conserved among placental mammals (i.e. eutherians), the 
morphology of the placenta is not (3). Here we discuss inter-specific placental variation 
in terms of how major characteristics of placental morphology differ within the eutherian 
mammals. Specifically, we focus on the shape of the placenta, the intimacy of the 
maternal-fetal interface, and the interdigitation pattern of the trophoblast in relation to 
the maternal tissue (4). We then discuss how these characteristics can shed light on 
multifactorial obstetrical syndromes associated with human placental dysfunction. 
Lastly, we examine how environmental stressors such as hypoxia and poor nutrition can 
drive placental plasticity, and how adaptations to these stressors can provide insight 
into the etiology of obstetrical syndromes (5-7).  
Placental Variation in Eutheria: 
The placenta is arguably one of the most variable organs in the animal kingdom. 
There are many characteristics that can be used when comparing the placentas of 
different species. Here we focus on three of the four major and most variable 
characteristics (placental shape, intimacy of maternal-fetal interface, and placental 
interdigitation). The fourth major feature involves the arrangement of the maternal and 
fetal bloodstreams (4). This feature partially determines the physiological diffusion 





Unfortunately, this feature has not been described in enough mammalian species to 
accurately reconstruct its evolutionary history. Humans have a relatively inefficient 
multimillions exchange system (4). The other three major features of the placenta are 
better described across mammalian diversity.  The placental shape describes the 
pattern that makes contact with the uterine wall where nutrient exchange occurs. The 
maternal-fetal interface describes the type of barrier that separates the maternal and 
fetal tissue. Placental interdigitation refers to how the trophoblast and maternal blood 
supply are interwoven. These, as well as other characteristics can be used to study 
different aspects of placental and fetal development. 
There are five commonly described placental shapes that are found among 
eutherians (4). The most common placental shape is the discoid placenta where the 
placental tissue makes contact with the uterine wall in the shape of a single disc. This 
shape was present in the most recent common ancestor of placental mammals (3, 8, 9). 
The zonary placenta was the first shape to diverge from the ancestral discoid placenta 
and is present in some afrotherians such as the members of Sirenia and the African 
elephants as well as the carnivores of the laurasiatherian clade (3, 9-12).  Another 
evolutionarily derived placental shape is the diffuse placenta present in some primates 
and most of the cetartiodactyls (i.e. cetaceans and artiodactyls) except bovines (3, 4). 
The diffuse placenta has a large surface area for contact between the fetus and the 
uterine wall allowing a high surface area for maternal-fetal nutrient exchange. Bovines 
have a cotyledonary placental shape which is characterized by many “polka dot” like 
attachments to the uterine wall (4). Among primates, there are three different placental 





humans, other apes, some catarrhines and platyrrhines, and the bidiscoid placenta (i.e. 
the placenta attaches to the uterine wall as two discs that share an umbilical cord). In 
this case, one disc attaches on the anterior and the other disc attaches to the posterior 
wall of the uterus (4). The bidiscoid placental shape is found in a subset of anthropoid 
primates including some macaques and marmosets (3). The different placental shapes 
among eutherians indicates varying amounts of contact between the mother and the 
fetus, with the diffuse placenta typically having relatively the most and the discoid 
having the least surface area for contact and nutrient exchange (13). 
Another way to compare and classify placentas of different species is through 
looking at differences in their interdigitation pattern, or the way the fetal tissue interacts 
with the maternal tissue (14). There are five different types of placental interdigitation 
observed in eutherians (labyrinthine, villous, trabecular, lamellar, and folded) (4). The 
most recent common ancestor of placental mammals is inferred to have had a 
labyrinthine pattern of interdigitation (3). This pattern is present in most placental 
mammals including all afrotherians, Glires (rodents, rabbits and allies), soricid shrews, 
moles, hedgehogs and bats (3, 15, 16). One characteristic of the labyrinthine 
interdigitation pattern is web-like channels containing either maternal or fetal blood (4). 
When xenarthrans (e.g. sloths, armadillos, anteaters) diverged from the other placental 
mammals they evolved a trabecular interdigitation pattern, in which globular folds of 
trophoblast terminate in branching villi like tubes known as trabeculae (3, 17). Three 
different types of placental interdigitation are present in Euarchontoglires. Rodents, 
lagomorphs, scandentians, and dermopterans have a labyrinthine interdigitation pattern. 





platyrrhines, or a villous interdigitation pattern seen in catarrhines and strepsirrhines 
(Figure 1.1a). In catarrhines, fetal villi project into the maternal endometrium (18)(Figure 
1.1b).  One feature that distinguishes platyrrhine trabeculae is the presence of 
prominent maternal channels lined with endothelium (19). Within Laurasiatheria, 
perissodactyls and artiodactyls have a villous interdigitation pattern, with the exception 
of pigs, that have a folded interdigitation pattern, i.e. fetal tissue folding in and out of 
maternal tissue. Some carnivores have a more complex folding pattern known as a 
lamellar interdigitation. Two crown laurasiatherian orders maintain the ancestral 
labyrinthine interdigitation, and these are Soricomorpha and Chiroptera (4).  
One of the most studied characteristics that can be used to classify eutherian 
placentas is the type of interface between the fetal tissue and the maternal blood (4). 
They range in levels of intimacy, i.e. the degree of separation or number of layers 
separating the fetal and maternal tissues. The least intimate is the epitheliochorial 
placenta where there is a layer of uterine epithelial cells apposed to a layer of 
trophoblast cells, limiting interaction between the maternal blood and fetal tissue 
(4)(Figure 1.2a). This type of barrier has evolved independently multiple times during 
eutherian evolution, and it is a derived character state (13)(Figure 1.3). The second 
most invasive barrier is the endotheliochorial interface where, after implantation, the 
uterine epithelium is degraded leaving only the maternal endothelium adjacent to the 
trophoblast (Figure 1.2b). The endotheliochorial interface is found in some afrotherians 
(elephants and aardvarks), some Euarchontoglires (tree shrews), and some 
laurasiatherians (moles, most carnivores and some chiropterans) (13). The most 





maternal epithelial cells and maternal endothelial cells are degraded leaving only the 
trophoblast cells in direct contact with the maternal blood (Figure 1.2c). This is the most 
widespread type of interface present in all four of the major eutherian superordinal 
clades (i.e. Xenarthra, Afrotheria, Laurasiatheria, and Euarchontoglires). The 
hemochorial interface has also been inferred to represent the ancestral state of extant 
placental mammals (3, 8)(Figure 1.3). The hemochorial arrangement has also been 
described to vary in the number of trophoblast layers that surround the syncytium (20). 
The hemomonochorial placenta has a layer of syncytium not surrounded by 
cytotrophoblast, hemodichorial placentas have a layer of cytotrophoblast on the fetal 
side of the syncytium; and lastly, the hemotrichorial placenta syncytium is surrounded 
by a layer of cytotrophoblast on the maternal and fetal sides (4, 20). A hemochorial 
state requires the tolerance of the maternal immune system towards paternal antigens 
since the placental tissue expresses both maternal and paternal antigens (21). If 
immune tolerance is disrupted, problems with placental function may occur (22). The 
great variation in placenta morphology across the eutherian mammals makes it more 
complicated to design animal models to study human diseases associated with 
placental dysfunction. 
Comparative placental transcriptomics: 
 Sequencing technology allows us to identify genes that are differentially 
expressed across the different eutherian mammals. One study involving the placenta 
transcriptome used next generation sequence technology to sequence the placenta 
transcriptome of the African elephant (Loxodonta africana) and compared it to 





chickens. Roughly 3,000 genes were expressed in the placentas of all sampled 
eutherians. The list of these genes is overrepresented by genes associated with many 
annotations including 128 genes related to stress, (e.g. corticosteroid signaling). One 
class of corticosteroid, glucocorticoids, has increased expression in cases of reduced 
fetal growth (23, 24). The conservation of corticosteroid signaling gene expression in 
the placenta suggests an ancient origin of the mechanism of response to stress across 
eutherian mammals. Other studies have used placenta transcriptomes of several 
equines to study parent of origin effects and genetic imprinting, where the fetus inherits 
genes from either the mother or the father (25, 26). One study compared placental 
transcriptomes of horses, donkeys, and their crosses (mules and hinnies) and found 
that a majority of the genes that were significantly different were paternally expressed, 
showing that the father’s size has some influence in determining the size of the fetus 
(25). 
 Placental transcriptomics has also identified novel splice variants that are 
processed differently in various eutherian species. Prolactin (Prl) for example, a gene 
involved in regulating lactation in placental mammals, has many alternative transcripts 
(27). Placental mammals such as dogs and armadillos show no evidence of a 
myometrial Prl transcript; while humans, some New World monkeys, mice, and 
elephants all express Prl transcripts; however, each species expresses different splice 
variants with alternative transcription start sites (28). Another gene that has multiple 
alternative transcripts across the placental mammals is the gene encoding aromatase 
(CYP19). Aromatase converts androgens into estrogens, and thus plays a role in 





bovines, ovines, and humans, but not rodents (29, 32, 33). The human CYP19 isoform 
contains a long terminal repeat (LTR) that functions to localize CYP19 to the 
syncytiotrophoblast (29, 34). This LTR is most likely an endogenous retrovirus. This 
retrovirus was integrated into a promoter region, and therefore effects transcription of 
the gene. Endogenous retrovirus integration may have played a role in the evolution of 
the primate placenta (29). Other human genes that play a role in placental development 
and function and contain endogenous retroviruses include the syncytins (encoded by 
ERVW-1 and ERVFRD-1). Syncytin-1 plays a role in cell fusion during trophoblast 
formation and is expressed throughout pregnancy. The main role of syncytin-2 is the 
suppression of the maternal immune system but unlike syncytin-1, expression declines 
as pregnancy progresses (29, 35). It has been shown that down regulation of syncytin-1 
is associated with preeclampsia (36). Interestingly, syncytin genes have evolved 
independently over the course of eutherian evolution (37). Mice for example, also 
express a pair of syncytins, syncytin-A and syncytin-B. Like syncytin-2, syncytin-B has 
immunosuppressive properties not seen in syncytin-1 or syncytin-A, both of which play 
a role in cell fusion during syncytiotrophoblast and trophoblast giant cell formation 
respectively (37). The blind mole rat placenta expresses SynA and SynB, but these 
genes are not present in the naked mole rat genome (38). The human syncytin genes 
have trophoblast specific enhancers that contain binding sites for transcription factors 
such as glial cell missing 1 (GCM1), that induce the expression of the syncytins (39). 
GCM1 is a transcription factor that is specifically expressed in trophoblast cells and has 





41). Other genes that have been shown to have placental specific promoters or 
enhancers include rat placental lactogenlactose 2 (rPLII) and AP-2 (42, 43).   
There are other larger gene families that have placenta specific members (29). 
One example is the human leukocyte antigen (HLA) gene family. HLA-g is a placenta 
specific immune system gene that plays a role in trophoblast invasion (44). Another 
example of a eutherian specific gene expressed in placenta that acts differently in 
various eutherian species is placenta specific 1 (PLAC1) (45). This gene is mainly 
expressed in the placenta but may also be expressed in the testis (29, 46). Orthologs of 
PLAC1 are found only in placental mammals (29, 45, 46). PLAC1 is expressed all 
throughout gestation in humans but only during e7.5 through e14.5 in rodents (47, 48). 
Galectins are another gene family with placenta specific members that play a role in the 
maternal-fetal immune tolerance and implantation (49). All members of this family are 
expressed at the maternal-fetal interface (50). The placenta-specific galectins are 
located in a cluster on chromosome 19. This chromosome contains many placenta 
specific genes including the pregnancy specific glycoproteins and a cluster of placenta 
specific microRNAs (51, 52). 
Animal models for placental dysfunction: 
 Due to the wide variation among placental mammals, it is challenging to develop 
animal models of obstetrical syndromes associated with placental dysfunction (53, 54). 
While some mouse models have been used to study obstetrical syndromes associated 
with placental dysfunction such as implantation failure, miscarriages, and preeclampsia, 
the results may not be directly relevant to the human condition (54-57). One difficulty to 





invasion of the fetal tissue into the maternal decidua (21). Human placentas typically 
have a deeper invasion into the maternal myometrium than mice and since 
preeclampsia is characterized by relatively shallow trophoblast invasion (i.e. the typical 
condition in mice); studies of reduced placental invasiveness may be difficult to model 
using mice (58).  Also, the cellular makeup of the murine placenta is different than the 
human placenta. Mice have polyploid trophoblast giant cells. Like human 
cytotrophoblast cells these giant cells regulate uterine implantation. Mice also have a 
layer of spongiotrophoblast similar to the human extravillous trophoblast (59). Sheep 
have also been used to study placental dysfunction (60). Sheep pregnancy has been 
used to model human intra-uterine growth restriction by inducing maternal hypothermia, 
removing of endometrial caruncles to limit placental growth, limiting blood supply 
through the restriction of uterine blood flow, and maternal over nutrition (60). All of these 
methods result in altered oxygen and nutrient transfer leading to a decrease in fetal 
growth (60). Guinea pigs have also been used to model human placentation because 
they share features with humans (54). Guinea pigs have smaller litter sizes, longer 
gestation, and deeper trophoblast invasion than other rodents (54, 61). Guinea pig 
models have been developed to study placental transfer and intra-uterine growth 
restriction (54, 62, 63). 
 Preeclampsia is an example of an obstetrical syndrome related to shallow 
trophoblast invasion (64, 65). In preeclampsia, the spiral arteries that supply maternal 
blood to the developing fetus are poorly remodeled due to decreased trophoblast 
invasion; therefore, blood supply to the fetus may be limited (66-68). Some studies have 





especially in those with a bidiscoid placenta such as the rhesus monkey (69, 70).  
Preeclampsia is typically thought to be a human specific syndrome (69, 71). However, 
recent work has challenged this view, primarily due to the fact that placental 
invasiveness is also quite deep in the closest relatives of humans, chimpanzees and 
gorillas (72-74). Thus it is likely that the potential for preeclampsia due to dysregulation 
of placental invasiveness predated the most recent common ancestor of humans, 
chimpanzees, and gorillas during the Miocene. A recent study supporting this 
hypothesis, examined the evolution of orthologous protein coding gene sequences and 
found evidence for adaptive evolution (i.e. positive selection as measured through 
comparison of nonsynonymous and synonymous substitution rates) in genes associated 
with the more invasive phenotype seen on the evolutionary lineage leading to the most 
recent common ancestor of these three species (75). In particular, genes associated 
with immune function, regulation of blood vessel size, and hypertension were enriched 
among the adaptively evolving genes. These findings suggest that the molecular 
mechanisms for the induction of preeclampsia were in place long before the evolution of 
modern humans. 
Natural human models for studying placental dysfunction: 
 While animal models can be useful for studying specific symptoms associated 
with the complex diseases involving placental dysfunction, some researchers have 
begun using environmentally variable, natural human models to study the genetic and 
morphological differences associated with placental dysfunction (6, 76, 77). The human 
placenta brings practical advantages to biomedical studies as it is a temporary organ 





been used to study placental morphology in regard to placental dysfunction are high 
altitude natives as well as multigenerational populations who experienced periods of 
poor nutrition in at least one generation (5, 6). 
 Populations native to high altitude, such as native Andeans and Tibetans, are 
candidates to study how hypoxic conditions affect the placenta and contribute to 
complex obstetrical syndromes such as intra-uterine growth restriction and 
preeclampsia (5, 77). These populations also allow for a case-control type experimental 
design in which high altitude native populations are used as the case populations and 
natives in low altitude regions can be used as the control populations (76). The natives 
of the Tibetan Plateau and Andes Mountains have been exposed to hypoxic conditions 
for roughly 20,000 and 10,000 years respectively (78, 79). Infant cohorts exposed to the 
hypoxic conditions of high altitude during gestation experience lower than average birth 
weights when compared to their sea-level counterparts (80). The exceptions to this 
pattern are infant cohorts born to mothers who have an ancestral pattern of high altitude 
hypoxia. These infants exhibit birth weights comparable to those at sea level suggesting 
some level of adaptation to the hypoxic environment (79). Morphological studies of 
placentas of high altitude dwelling individuals show an increased capillary surface area 
and greater placental weight. These features combine to increase the total area for 
oxygen exchange between the mother and fetus (81). Physiological studies have shown 
that Andeans and Tibetans are different at high altitude with Tibetans being more 
adapted to high altitude with attributes more similar to sea level populations (78). 
Genetic studies have shown that differences in the genetics between Andean and 





populations (79, 82, 83). Recently, a genome-wide study compared two populations 
native to high altitude for several millennia: 1) the native inhabitants of the Tibetan 
Plateau and 2) the Native inhabitants of the Andean Altiplano of South America. These 
populations have been exposed to chronic hypoxia, using low altitude individuals as 
control populations. In 2010, Bigham et. al. were able to identify gene regions and 
single nucleotide polymorphisms (SNPs) that show evidence of positive selection (i.e. 
adaptive evolution). Of the dozens of genes identified, one deserves special attention. 
EGLN1, encodes hypoxia-inducible factor prolyl hydroxylase 2, a protein that regulates 
the expression of HIF-1a, the transcription factor responsible for the hypoxic response 
(84). EGLN1 shows evidence for positive selection at 25 SNPs in Andeans and 28 
SNPs in Tibetans (83). This finding suggests there is a genetic basis for the adaptation 
to hypoxia in these populations, and future work should test how these positively 
selected SNPs effect the oxygen exchange between the mother and fetus via the 
placenta. This is important since recent migrants to high altitude tend to have offspring 
with relatively low birth weights compared to their native counterparts who have evolved 
adaptions to hypoxia (85). 
 Another class of human populations that have shed light on placental plasticity 
are those in which pregnant woman were exposed periods of low nutrient availability 
during all or part of their pregnancy. One of the first studies using famine as a mediator 
of fetal growth and development examined samples from a Dutch population whom had 
suffered through the famine during the second World War (6). Famine studies have 
shown that those women who were exposed to famine conditions during their third 





availability (6, 86). Those who experienced famine conditions during their first trimester 
produced offspring with heavier placentas. This was thought to be an adaptive 
mechanism to allow for increased surface area for nutrient exchange (7).  
 Epigenetic studies have also examined placental gene expression and placental 
methylation differences in famine populations and those individuals with low birth 
weights. They found differential expression in genes associated with fetal growth as well 
as differential methylation in those growth related genes (87-89). One study examined 
differential methylation along insulin-growth factor 2 (IGF2)(89), a gene known to 
promote fetal growth (90). This study used whole blood from 60 individuals conceived 
during the Dutch famine and compared them to their control, same sex, siblings born 
before or conceived after the famine (89). The study describes five methylation sites 
along the promoter region of IGF2 and found decreased methylation across all sites in 
the famine-exposed individuals when compared to the control siblings. This finding 
suggests that during times of low nutrition, genes such as IGF2 can be differentially 
methylated and potentially provide a link between maternal nutrition and fetal gene 
expression (89). These results add another layer of placental adaptation in which during 
times of low nutritional availability, the placenta responds by either expanding in size to 
increase surface area of nutrient exchange or repressing genes associated with fetal 
growth in order to protect the mother. 
 Low birth weight as a result of poor maternal nutrition not only affects the 
conceptus during fetal development but also impacts their adult life (91). According to 
the Developmental Origins of Health and Disease (DOHaD) paradigm, low fetal birth 





in life (92). This has been hypothesized to be an adaptive mechanism, as the fetus has 
become accustomed to the low nutrient environment in the womb. Later, if the child is 
exposed to a healthy, more enriched diet after birth, their body reacts differently than 
would children who had sufficient nutrients during fetal development. This reaction to a 
more enriched diet after birth can result in poor outcomes later in life including obesity 
and obesity related conditions (93). 
Parent - Offspring Conflict: 
Robert Trivers pioneered investigations on the conflict between the parents and 
offspring. Trivers defined parental investment as, “any investment by the parent in an 
individual offspring that increases the offspring’s chance of surviving (and hence 
reproductive success) at the cost of the parent’s ability to invest in other offspring” (page 
139) (94). In this manner, the survivability of future offspring is affected if the current 
offspring takes an excess amount of maternal resources limiting the amount of 
resources available to the offspring’s future siblings (95). 
 David Haig extended the idea of parental-offspring conflict by adding that there 
is also conflict between the mother and the fetus. In this view, the fetus aims to extract 
the maximum amount of maternal nutrients (thus engendering conflict), but the mother 
and the fetus must also cooperate during a normal pregnancy (96, 97). Trophoblast 
invasion is an example of a balance between maternal-fetal conflict and cooperation. 
During a normal human pregnancy, the trophoblast invades into the maternal 
myometrium and extracts nutrients from maternal blood (98). Conflict arises because 
while the mother wants to limit trophoblast invasion, the placenta invades deeply 





invasion. Optimal placenta invasion is deep enough into the maternal tissue ensuring 
the fetus can absorb enough nutrients but shallow enough to protect the mother from 
syndromes such as placenta accreta (98). One obstetrical syndrome that is related to 
the improper balance of conflict and cooperation is preeclampsia. Conflict theory 
suggests that fetal actions need to be distinguished from maternal responses in 
preeclampsia (98, 99).  
General conflict between the mother and the fetus can be mediated by genetic 
processes such as gene imprinting. Imprinted genes are those genes in which only one 
parental allele is expressed, while the other allele is silenced through mechanisms such 
as DNA methylation (100, 101). Conflict theory predicts that maternally expressed 
imprinted genes restrict fetal growth by retaining maternal resources. In contrast, 
paternally expressed imprinted genes promote fetal growth and maximize resource 
extraction (102, 103). Despite the conflict arising from genomic imprinting, cooperation 
between the mother and fetus is important in regard to nutrient exchange and fetal size. 
If the mother fails provide the fetus with enough resources, the fetus will have a low 
birth weight, which leads to complications later in their adult life, and possibly reduced 
reproductive success (91, 92).  
Cooperation can also be observed in the maternal immune system because it 
tolerates non-self paternal antigens expressed in the placenta, which is considered a 
semi-allograft (18, 104). Obstetrical syndromes such as preeclampsia have been 
posited to result from excessive conflict between the mother and the fetus as well as a 
breakdown in maternal-fetal cooperation (105). This balance of cooperation and conflict 





placenta has more contact with maternal blood (and by extension paternally expressed 
alleles), than in less intimate endotheliochorial and epitheliochorial placentas (18). 
Conclusions: 
 The placenta varies across eutherian species and this variation should be 
considered when developing animal models to study human diseases associated with 
placental dysfunction. While many animal models have mimicked several of the 
symptoms associated with placental dysfunction, it is unsure how applicable any of 
these results would be to the human condition (21). One possible approach would be to 
examine naturally occurring conditions that in humans are associated with obstetrical 
syndromes. For example, species with less intimate maternal fetal interfaces (e.g. 
artiodactyls, lemurs) might be appropriate models for preeclampsia, because the 
syndrome is characterized by less placenta invasion (75). Primate models, including 
natural examples of environmental stress in humans are promising because factors 
such as hypoxia or nutritional stress modify the placenta, and therefore provide insight 
into complex obstetrical syndromes associated with placental dysfunction. 
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Figure 1.1: Placental Interdigitation across primates: 
Cross-sectional view of two types of maternal-fetal interdigitation found in primates: 
trabecular (a) and villous (b). The trabecular interdigitation pattern is characterized as 
branching globular folds that terminate in villi and this is seen in tarsiers and 
platyrrhines. The fetal trophoblast cells (red) surround the fetal villi (purple), which 
contain fetal blood (purple) separating the fetal blood from the maternal blood located in 
the intervillous space. The villous interdigitation pattern is found in catarrhines and 
strepsirrhines, and this is characterized by a branching villi pattern (4). TR= trophoblast 



















Figure 1.2: Three types for interface between the mother and the fetus 
Histological examples of the three different levels maternal fetal interface seen across 
the eutherians. A is section of placental tissue from a giraffe which has an 
epitheliochorial interface where the mother and the fetus is separated by layer of uterine 
epithelial cells (EPI) and maternal endothelial cells (ENDO). B is an example of an 
endotheliochorial placenta of a three toed sloth originally from (12). This type of 
placenta has one layer of maternal; endothelial cells (ENDO) separating the maternal 
blood from the fetal trophoblast. C is an example of a hemochorial placenta of a degu, a 
rodent from (106). The hemochorial placenta is the most invasive maternal-fetal 
interface with fetal trophoblast in direct contact maternal blood. ENDO: Fetal Endothelial 
Cells, EPI- Maternal Epithelial Cells. Syn TR: Syncytiotrophoblast, FC: Fetal Capillary, 








Figure 1.3: Evolution of the maternal fetal interface 
Maximum parsimony phylogenetic reconstruction of the maternal-fetal interface of 141 
mammals through parsimony analysis showing the root placental mammal having a 
hemochorial placenta (white) with epitheliochorial (black) and endotheliochorial (green) 








CHAPTER 2: INTRODUCTION TO THE DISSERTATION 
Understanding how human physiological variation is affected by adaptation is a 
major goal of biology. An extreme environment in which humans show evidence of 
adaptation is high altitude. Some of the factors that affect the high altitude environment 
are decreased temperature, increased ultraviolet radiation, and decreased partial 
pressure of oxygen. One population that has adapted to the high altitude environment 
are the long-term inhabitants of the South American Altiplano (79). These native 
Andean populations, which have resided at high altitude for 10,000 years, have altered 
physiological parameters such as decreased pulmonary oxygen pressure, elevated 
hemoglobin concentrations, elevated pulmonary arterial pressure and, decreased 
resting ventilation when compared to their sea-level dwelling counterparts (112-115). 
Despite these differences in adult physiology, the Andeans give birth to children with 
birth weights similar to what is seen in birth weight in sea-level populations (79). When 
the Spanish settlers arrived in the Andes roughly 450 years ago, they did not have the 
adapted physiological toolkit that affords protection to the high altitude environment that 
the natives had and thus experienced decreased reproductive success (116).  
European mothers that move to a high altitude environment during their lifetime 
and later become pregnant experience a two to four fold increase in obstetrical 
syndromes such as preeclampsia and intrauterine growth restriction (IUGR) (117). This 
observation stands in contrast to long-term inhabitants of high altitude such as Native 
Andeans who do not show such a marked risk increase for obstetrical syndromes. 
Additionally, reduced fetal growth is associated with the development of metabolic 





role in fetal growth as it acts both as a barrier, and as mediator for maternal-fetal 
nutrient transport (1). Therefore, there is some evidence that adaptations in pregnancy 
have occurred in Native Andean residents in high altitude. While there have been many 
studies that have examined morphological and physiological differences between high 
and low altitude populations, to our knowledge, little has been done to identify the 
genetic and epigenetic factors related to the Andean placental adaptation to high 
altitude.  
To study adaptation to high altitude, we examined healthy placental tissue from 
individuals residing in Santa Cruz and La Paz, Bolivia, located at 400m and 3600m, 
respectively. At each altitude, we studied populations of 1) Aymaran speaking (AS) 
Andean and 2) European descent who have resided at high altitude for at most 10,000 
and 450 years, respectively. The rationale for selecting these populations was that 
Europeans living at high altitude have significantly lower birth and placental weights 
when compared to AS Andeans living at high altitude, demonstrating that AS Andeans 
have potentially adapted to the high altitude environment through 10,000 years of 
habitation. Through examining genetic and epigenetic signals we expect to be able to 
identify pathways that may contribute mechanistically to the placental adaptation to high 
altitude. We  measured placental gene expression patterns and test for differential gene 
expression to determine what biological processes are involved in placental adaptation 
at high altitude. We identified candidate genes that are differentially expressed between 
Andeans and European descendants at both low (Santa Cruz, Bolivia) and high altitude 
(La Paz, Bolivia). Once regions of differential expression were determined, we 





DNA methylation within regulatory regions.  
The central goal of the proposed research was to determine which genetic and 
epigenetic factors contribute to the Andean adaptation to the environmental 
stress acting on the placenta at high altitude. To accomplish this, we conducted the 
following specific objectives: 
Specific Objective 1: Test for differences in gene expression and DNA methylation that 
contribute to the placental adaptation to high altitude seen in Andean populations. 
Hypothesis: Gene expression differences and DNA methylation contribute to the 
response or adaptation to high altitude stress acting on the placenta. 
Specific Objective 2: Test if natural selection influenced placental gene expression 
and DNA methylation differences between individuals of Andean and European descent 
residing at high altitude. 
Hypothesis: We predicted there would be methylation differences associated with 
differentially expressed genes involved in fetal growth related pathways between high 






CHAPTER 3: DNA METHYLATION EXPLAINS ROUGHLY ONE THIRD OF 
PLACENTAL GENE EXPRESSION DIFFERENCES BASED ON ANCESTRY AND 
ALTITUDE 
Abstract: 
Objectives: The most pronounced effect of high altitude (>2700m) on reproductive 
outcomes is reduced birth weight. Indigenous Bolivians (Andean Native Americans) 
residing for generations at high altitudes have higher birth weights relative to more 
recent migrants of primarily European ancestry. Previous research demonstrated that 
the placenta is a key contributor to the preservation of Andean birth weight at high 
altitude. Our current research investigated how gene expression and epigenetics 
contribute to the conservation of birth weight at high altitude by examining mRNA 
expression and DNA methylation differences between placentas of Andeans and those 
of European ancestry residing at high and low altitude.  
Methods: Genome-wide mRNA expression and DNA methylation of villous placenta 
tissue was quantified utilizing microarray technology. Subjects were of Andean and 
European ancestry and resident at high (3600m) or low (400m) altitudes. Differentially 
expressed genes (DEGs) associated with altitude or ancestry were identified (FDR<0.1, 
|fold change|>1.25). To predict which DEGs could be regulated by methylation we 
tested for correlation between gene expression and methylation values. 
Results: 70 DEGs associated with altitude (n=36) or ancestry (n=35) were identified. 









Ancestry-associated DEGs were implicated in inflammatory pathways and associated 
with pro-angiogenic macrophages. More ancestry-associated DEGs correlated 
significantly (n=17) (FDR<0.1) with promoter or gene body methylation (p=0.0242) when 
compared to altitude associated DEGs (n=8).  
Conclusions: Compared to altitude-associated DEGs, methylation regulates more 
ancestry-associated DEGs, potentially allowing for rapid modification in the expression 
of inflammatory genes to attract pro-angiogenic macrophages as a means of promoting 
placental capillary growth in Andeans, regardless of altitude. 
Introduction: 
The placenta mediates fetal growth by orchestrating nutrient and gas exchange 
between the mother and the fetus (118). We have shown there is altered substrate 
delivery from placenta to fetus under conditions of chronic maternal hypoxemia (lowered 
arterial oxygen tension due to high-altitude residence). High altitude environments 
contributes to reduced birth weights in humans, with a gradient of reduction in birth 
weight that corresponds to the evolutionary duration of population exposure to high 
altitude (119-121). At ≥3000 meters, Tibetans and Andeans have higher birth weights 
than more recent migrants such as European and Han (Ethnic Chinese) (120, 122). The 
Andeans, with a population history of ~10,000 years at high altitude have birth weights 
>200 grams higher than Europeans at ≥3000 meters (119, 120, 123, 124). This 
suggests a relatively rapid adaptation to the high altitude environment in terms of the 
promotion of favorable reproductive outcomes among Andeans. Recent analyses have 
shown Tibetan and Andean populations have undergone natural selection to favor 





possibly regulation of vascular tone (83, 121, 125). However, prior work looking at gene 
expression in relation to altered physiological function has only looked at gene 
expression differences in leukocytes so in order to begin to related gene expression to 
physiological function we need to look at expression patterns in a reproductive tissue 
such as the placenta. We hope that by identifying differential gene expression of genes 
previously associated with physiological processes associated with the placenta such 
as angiogenesis and immune response, we can begin to identify how these processes 
may be contributing to the conservation of birth weight seen in the native Andeans 
residing at high altitude. 
Reduced birth weight in a population subjected to environmental stress is said to 
be disadvantageous because reduced birth weight is associated with increased 
fetal/neonatal morbidity and mortality (126). Lowered birth weight is also associated with 
an increased risk for chronic diseases later in life, including cardiovascular and 
metabolic diseases (127, 128). Hence placental adaptations that protect against growth 
restriction not only benefit offspring survival, but also population-wide health in later life. 
The accumulated data suggests that at high altitude, there is diminished vascular 
elasticity, consistent with the reduced uterine arterial and fetal umbilical venous blood 
flow we and others have reported in high-altitude residents (128-132).  
 The greater fetal growth in Andean Native Americans is associated with higher 
uterine arterial and umbilical venous blood flows compared to more recent migrants to 
high altitude (129, 130). Our prior work found no relationship between oxygen-
associated variables such as maternal and fetal PO2, arterial oxygen content and birth 





accounting for 35% of the variation in birth weight in both Andean and European women 
at high altitude (130). Also, greater blood flow from the umbilical artery was seen in 
individuals of Andean descent residing at high altitude compared to their European 
counterparts residing in the same location as well as increased oxygen delivery which 
may also aid in protecting the Andeans against altitude associated reduced fetal growth 
(133).  Along with higher umbilical blood flow between Andeans and Europeans residing 
at high altitude where was a decrease in the anti-angiogenic factor fms-like tyrosine 
kinase (sFlt-1) suggesting that increased angiogenesis may also be aiding in the 
increased birth-weights seen among the native Andeans at high altitude (134). 
Moreover, for any given placental weight, Andean neonates were larger than 
Europeans, indicative of greater placental efficiency among Andeans. For these 
reasons we proposed that the ancestry differences we have reported are due to 
changes in placental function (130, 135). This was the stimulus for the present study, in 
which we hypothesize that differences in placental gene expression contribute to the 
greater growth of the Andean fetus at high altitude.  
 Previously, other studies have examined the role of DNA methylation in 
hypertensive pregnancies utilizing DNA extracted from peripheral blood mononuclear 
cells(136-138). To our knowledge, global gene expression and DNA methylation in 
placental tissue has never been examined relative to ancestry, nor to an environmental 
challenge such as high vs. low altitude. It is important to compare DNA methylation and 
gene expression in the same tissue because both DNA methylation and gene 
expression patterns are tissue specific. While we understand that methylation in 





effects, we are focusing on local (cis) methylation as it is more understood. Our 
approach was to compare the gene expression signatures of placentas from indigenous 
Andeans to those of more recent migrants, most of whom are the descendants of 
European colonists residing at high and low altitude in Bolivia (<500 years). The 
ancestry-associated DEGs may provide insight into how the Andean placenta has 
adapted to protect the fetus from altitude-associated reduction in birth weight. Altitude-
associated DEGs may provide new biomarkers for, or even point towards therapeutic 
options for hypoxia-related placental pathologies such as preeclampsia and idiopathic 
intrauterine growth restriction.  
 We also investigated how DNA methylation correlates with gene expression in 
the altitude or ancestry-associated DEGs. We reasoned that the ~10,000 year exposure 
of Andeans to the high altitude environment is generally considered long enough for 
evolution by random mutation and subsequent selection. Adaptions including lactase 
persistence have occurred in less time with lactase persistence developing in roughly 
9000 years(139). The Andean plateau, while long, is narrow, and undoubtedly 
prehistoric populations moved between altitudes(140). DNA methylation may explain 
how gene expression has been altered relatively rapidly in a temporary manner(141). 
An environmentally induced methylation event may allow for the alteration in gene 
expression after the germ cell sequence has been established(142). This allows for a 










The data reported here are derived from a subset of pregnancies studied in La 
Paz, Bolivia (altitude ~3600 m) and Santa Cruz, Bolivia (altitude ~400 m). The original 
studies were designed to examine maternal and fetal blood flow, oxygen delivery, and 
consumption in a four-way cross-sectional design comparing indigenous Andeans 
versus European migrants residing at high and low altitude (129). All women gave 
written informed consent to protocols approved by the Bolivian National Bioethics 
Committee, the San Andreas Mayor University, Instituto Boliviano de Biologia de Altura 
Consejo Tecnico, and the USA Institutional IRBs approved by the New Jersey Medical 
School. 
  Women completed an interview and questionnaire in which they identified the 
birthplace and residence history of themselves, their parents, their grandparents, and 
those of the baby’s father and his recent ancestors. Three generation residential history 
in the Altiplano region, Andean surnames, self-identification as, and fluency in Aymara 
or Quechua initially defined our Andean samples from both high and low altitude. 
Women who self-identified as Spanish or European, reported no known Andean 
ancestry, and who documented three generations of low altitude residence were 
provisionally assigned to the European group from both high and low altitudes. Ancestry 
was evaluated using 133 Ancestry Informative Markers (AIMs) to confirm self-identified 
ancestry and quantify admixture (130, 143, 144). The Andean women in this study had 
biogeographic ancestry profiles that were on average 86% Native American (95% 





sample population had an average of 63% European ancestry (95% CI 54-68%) and 
31% Native American (non-Andean) ancestry (95% CI 22-43%). Low levels of sub-
Saharan African (2-6%) and East Asian admixture (3-5%) were detected in both 
ancestry groups. There was no significant difference between altitudes in the measures 
of geographic ancestry, i.e. Andean individuals at low vs. high altitude did not differ in 
their proportional admixture, nor did those of European ancestry between the low and 
high altitude sites. Maternal inclusion criteria were conception, gestation and birth at 
altitude of residence, singleton pregnancy, a healthy mother age 18-45 with no known 
chronic disease, a normal glucose tolerance test, and the absence of any known 
pregnancy complications. 
Placental Sampling/Morphometrics 
All placentas were obtained from elective, non-laboring term cesarean deliveries 
without supplemental oxygen. Placentas were obtained immediately after delivery. The 
sampling strategy was designed to ensure multiple portions of the placenta were 
sampled, but also that RNA was collected as quickly as possible. Therefore, a semi-
random sampling strategy was used, in which the placenta was visualized as roughly 
circular and divided into four quadrants. One full-depth sample from approximately the 
center of each quadrant was excised, and the basal and chorionic plates were removed, 
and the core villous tissue minced. Tissue from all four quadrants was thoroughly mixed 
and 200 mg aliquots were flash frozen in liquid nitrogen for later RNA/DNA isolation.  
Each RNA/DNA aliquot, therefore, contained tissue from four regions of the placenta 
and was flash frozen in liquid nitrogen less than 30 minutes following delivery. For 





quadrant), formalin fixed and paraffin-embedded. Five of these samples were used for 
morphometric analyses following the methods originally described by Weibel et al (145, 
146), and as applied by Jackson and Mayhew (147-149) and Burton et. al.(150). 
Morphometric studies were overseen by DCM in consultation with Dr. Graham Burton of 
Cambridge University. The fetal membranes and umbilical cord were trimmed and the 
placentas were weighed. Placental volume was measured by water displacement, and 
correction for tissue shrinkage was based on maternal erythrocyte diameters (151). 
While complete morphometric analyses were undertaken of 20-30 placentas from each 
of the 4 low and high altitude groups, only data pertaining to vascular variables is 
considered here in relation to our microarray results. 
Nucleotide Isolation and Expression Microarray 
RNA was isolated from the core villous tissue of 45 placentas (n=10 Andeans 
from high altitude, n=12 Andeans born at high altitude but who migrated to low altitude, 
n=11 European individuals born at low altitude but who migrated to high altitude, and  
n=12 Europeans individuals born and residing at low altitude). The concentration and 
optical density of each RNA sample was measured using a NanoDrop spectrometer 
(Thermo-Fisher, Waltham MA). The quality of the RNA was further examined by 
calculating the RNA integrity number (RIN) using a Bioanalyzer (Agilent, Santa Clara 
CA). RIN score for all samples used for microarray array analysis ranged from 7.3 to 
4.6. One µg of RNA per sample was supplied to the Applied Genomics Technology 
Center at Wayne State University (Detroit, MI). The RNA was converted to cDNA and 
then hybridized to Illumina HumanHT-12v4 Expression BeadChips (Illumina, San Diego, 





beads using Illumina’s standard protocol. The average fluorescence intensity value for 
each probe set was calculated using the Illumina GenomeStudio software (Illumina, San 
Diego, CA). The probe sequences target more than 31,000 annotated genes. Samples 
were plated in random order across the different microarray chips on the same day to 
minimize batch effects. Intensity values for annotated genes were log2 transformed and 
quantile normalized using the Preprocesscore package from Bioconductor software 
collection in R (152). Probes located on the X- and Y-chromosomes were excluded 
because of sex-based dosage-dependent effects on gene expression. To compensate 
for our small sample size, we calculated the variance of each of the remaining probes 
and sorted them from highest to lowest variance and used the top 5% most variable 
probes leaving 1,523 probes to be used for further analysis (153). All raw files, non-
normalized intensity values as well as quantile normalized and log-transformed files 
have been uploaded to the GEO database (GSE100988). 
Determination of Differentially Expression Genes 
We tested for differential expression using a two-way analysis of covariance 
(ANCOVA) with the model, probe expression in proportion to altitude + fetal sex + 
gestational age or probe expression in proportion to ancestry + fetal sex + gestational 
age as well as testing for probe expression in proportion to the interaction between 
altitude and ancestry (Supplementary Table 3.1). P-values were generated from each 
independent variable and the false discovery rate (FDR) was estimated using the 
Benjamini-Hochberg (BH) method to adjust for multiple hypothesis testing (154). A 
probe sequence was considered to be significantly differentially expressed if it had an 





Validation of Microarray Data 
We conducted qRT-PCR using Taqman gene expression assays (Invitrogen, 
Carlsbad, CA) to validate the microarray results. 500ng of RNA from each sample was 
reverse transcribed to cDNA using the Superscript III First-Strand Synthesis system 
(Invitrogen, Carlsbad, CA). qRT-PCR was performed on the StepOnePlus real-time 
PCR machine (Applied Biosystems, Foster City, CA) with Taqman Fast Advanced 
Master Mix (Invitrogen, Carlsbad, CA) and fast cycling conditions. We tested six genes 
that were differentially expressed due altitude or ancestry and involved in inflammation 
and the AP-1 transcription factor pathway with qRT-PCR: lymphatic vessel endothelial 
hyaluronan receptor 1 (LYVE1, Taqman probe Hs00272659_m1), stanniocalcin 1 
(STC1, Taqman probe Hs00292993_m1), fos proto-oncogene (FOS, Taqman probe 
Hs99999140_m1), arachidonate 5-lipoxygenase-activating protein (ALOX5AP, Taqman 
probe Hs00233463_m1), nicotinate phosphoribosyltransferase (NAPRT, Taqman probe 
Hs00292993_m1), and phospholipase A2, group 2A (PLA2G2A, Taqman probe 
Hs00179898_m1). For each gene tested, samples were randomized and run in 
triplicate, incorporating a multiplexed 18S ribosomal RNA endogenous control (18S, 
Taqman probe Hs99999901_s1) in each well. The Ct values for each sample and gene 
were analyzed using the 2-ΔΔCt method (155). The qRT-PCR intensity value (Ct) for each 
gene was correlated with the intensity value yielded by the gene expression microarray 
to validate results from the gene expression microarray. 
Pathway Analyses 
 KEGG pathway enrichment analyses were performed separately on the altitude- 





(156). We used a hypergeometric test to determine which pathways were significantly 
over-represented within our lists of altitude- and ancestry-associated DEGs. A pathway 
was considered to be significantly over-represented if it had an FDR<0.05.  
Methylation Detection and Quantification 
We isolated DNA from the same villous placental tissues of the 45 individuals 
analyzed for gene expression. The DNA samples were bisulfite converted using the EZ 
DNA methylation kit protocol (Zymo Research, Irvine, CA) and hybridized to the Illumina 
HM 450k methylation microarray (Illumina, San Diego, CA) and scanned using the 
Illumina iScan Array Scanning System (Illumina, San Diego, CA) at the Applied 
Genomic Technology Center at Wayne State University (Detroit, MI). Fluorescence 
intensity values (i.e. β values) were calculated using the Illumina GenomeStudio 
software (Illumina, San Diego, CA), and a final report containing information for each 
probe was generated and preprocessed with the IMA (Illumina Methylation Analyzer) R 
package (157). After preprocessing, we used beta-mixture quantile normalization 
(BMIQ) to normalize type 1 and type 2 probe intensities (158). β values were logit 
transformed and quantile-normalized into M values to reduce the heteroscedasticity of 
the distribution across our samples (159). To restrict our analysis to determine which 
differentially expressed genes may be regulated by DNA methylation, which could 
potentially play a regulatory role in differential gene expression, we only analyzed 
probes located in the promoter or gene body of altitude- or ancestry-associated DEGs. 
Those genes that had a significant correlation between gene expression and cis-DNA 
methylation may suggest that the differences in gene expression. We defined the 





(TSS) through the 5’ untranslated region (UTR). We considered probes to be in the 
gene body if they were located downstream of the 5’UTR and upstream of the 3’UTR. 
By only analyzing methylation sites within gene bodies and promoter regions of 
differentially expressed genes we were able to avoid further interaction between DNA 
methylation and ancestry. To avoid further confounding, zero of the methylation sites 
analyzed in this study were associated with our ancestry informative markers, which 
were all located in non-coding regions. 
Correlation between Gene Expression and Methylation 
Pearson’s correlation test was used for the evaluation of correlation between the 
log2 intensity RNA abundance from gene expression microarrays and the M values of 
individual methylation probes within the promoter or gene body region of the identified 
DEGs in 42 samples for which we had both gene expression and DNA methylation data. 
Samples were excluded if we were unable to extract DNA with high enough quality for 
the methylation array. A correlation between gene expression intensity and M-value was 
considered to be statistically significant if the Pearson correlation test had an FDR<0.1. 
FDR was estimated for ancestry- and altitude-associated DEGs separately, similar to 
how it was estimated in the 2-way ANCOVA for gene expression. 
Results:   
Subjects / Placental Morphometrics 
The mothers in this study were similar to those of the larger parent study. 
Andean women were older and had higher gravidity and parity (Table 3.1). Non-
pregnant Body Mass Index (BMI) was similar across all four groups, as was gestational 





birth weights than European women, and less reduction in birth weight at high altitude. 
Because birth weights were lower, despite similar placental size, altitude reduced 
placental efficiency, reflected in the placenta:birth weight ratio (Table 3.1).  
Morphometric analyses of the placentas revealed greater vascularization in Andean vs. 
European placentas at high altitude as seen through greater capillary surface area and 
capillary volume (Table 3.1). Of the 45 placentas included in our microarray and 
methylation experiments, 42 had been used in prior studies where morphological data 
was collected (130). Relative to their low-altitude counterparts Andean subjects had an 
altitude-associated increase in capillary surface area, length and volume of 32%, 28% 
and 75% respectively (Table 3.1). These changes are greater than those in the total 
sample of low and high-altitude Andean placentae, in which these differences were 
25%, 15% and 38% respectively. Among Europeans there was a 0%, 9% and 4% 
increase in capillary surface area, length and volume respectively. Again, these data 
differ somewhat from the larger sample of European placentas analyzed (6%, <1%, 
23%). However, it must be remembered that the subset of subjects chosen for the 
genetic analyses represented the highest degree of Native American ancestry among 
Andeans and of European ancestry among the subjects of low-altitude origin.  
Placental Gene Expression  
In total, we identified 70 DEGs. Thirty-five genes (42 probe sequences) were 
differentially expressed between individuals of Andean and European descent (Figure 
3.2, Table 3.2) and 36 genes (36 probe sequences) were differentially expressed 
between individuals residing at high and low altitude (Figure 3.1, Table 3.3). One gene, 





with both ancestry and altitude. There were no significant differences between fetal 
sexes and across gestational ages among the genes used to test for differential 
expression (Supplementary Table 3.1). We tested six DEGs (LYVE1, STC1, FOS, 
ALOX5AP, NAPRT1, and PLA2G2A) using qRT-PCR and all showed a significant 
correlation with microarray expression, however after doing differential gene expression 
analysis were able to validate all but PLA2G2A validating the microarray analysis 
(Supplementary Table 3.2). Of the 34 ancestry-associated DEGs, ten had higher 
expression in European versus Andean placentas and 24 had higher expression in the 
Andean placentas (Table 3.2, Figure 3.2) (CD163) and lymphatic vessel endothelial 
hyaluronan receptor 1 (LYVE1) (160).  
Among the 36 altitude-associated DEGs, 24 DEGs had higher expression levels 
in placentas of individuals residing at high altitude compared to those residing at low 
altitude, whereas 12 DEGs were more highly expressed in placentas of individuals 
residing at low altitude (Table 3.3, Figure 3.1). DEGs with decreased expression in high 
altitude placentas compared to low altitude placentas, include fos (FOS), fosb (FOSB), 
and jun (JUN) proto-oncogenes, which form part of the activator protein 1 (AP-1) 
transcription factor family. The AP-1 transcription factor family plays a role in a variety of 
processes including angiogenesis, cell proliferation, and cytotrophoblast 
differentiation/fusion. Carboxypeptidase, vitellogenic–like (CPVL) was both an altitude-
associated and an ancestry-associated DEG, demonstrating decreased expression at 
high altitude and increased expression in Andean placentas. When we compared the 
gene expression patterns of the native Andeans at high altitude to the gene expression 





differentially expressed, and also shows higher expression in preeclampsia compared to 
healthy tissue(161). We found zero of our altitude associated DEGs were differentially 
expressed between Europeans residing at high altitude and Europeans residing at low 
altitude. 
To test for enriched KEGG pathways amongst the DEGs, over-representation 
analysis was conducted using GOstats (156). Enriched pathways (FDR<0.05) among 
altitude-associated DEGs include osteoclast differentiation (KEGGID: hsa04380) and 
rheumatoid arthritis (KEGGID: hsa05323); each involves DEGs within the activator 
protein 1 (AP-1) transcription factor family including JUN, FOS, FOSB, and early growth 
response 1 (EGR1). Enriched pathways among ancestry-associated DEGs included 
rheumatoid arthritis (KEGGID: hsa05323), allograft rejection (KEGGID: hsa05330), and 
graft-versus-host disease (KEGGID: hsa05332). These pathways include DEGs that are 
involved in inflammation and angiogenesis including HLA-A, HLA-DRB1, CCL2, and 
CCL3L3. 
Correlation of DNA Methylation with Gene Expression 
1,065 Illumina HM450k methylation microarray probes, each designed to 
measure methylation at a specific CpG site, were located within the promoter or gene 
body region of the 69 ancestry- and altitude-associated DEGs. 121 methylation sites 
correlated significantly with gene expression levels when corrected for multiple 
hypothesis testing (FDR<0.1) (Supplementary Table 3.3). 106 methylation sites had a 
significant correlation with expression levels of 17 ancestry-associated DEGs while 15 
methylation sites correlated significantly with expression levels of 8 altitude-associated 





(28/39) of the methylation probes located in a promoter region had a negative 
correlation with gene expression. Among these 39 probes, eighty-nine percent (8/9) of 
the probes among altitude associated DEGs had a negative correlation while sixty-six 
percent (20/30) of the probes among ancestry-associated DEGs had the same negative 
correlation. A negative correlation suggests that higher methylation values were 
associated with lower gene expression and vice versa. Some ancestry-associated 
DEGs that had a significant negative correlation between gene expression and 
promoter DNA methylation included the cell surface markers HLA-DRB1, HLA-A, CPVL, 
and LYVE1. Altitude-associated DEGs showing a negative correlation (i.e. Increased 
DNA methylation being associated with decreased gene expression and vice versa) 
included genes involved in the response to oxidative stress and inflammation such as 
gliomedin (GLDN), TYRO protein tyrosine kinase binding protein (TYROBP), dysferlin 
(DYSF), and CPVL. 
In addition to promoter region methylation, 69% (58/84) of the methylation probes 
that correlated significantly within gene bodies showed a pattern of negative correlation 
with gene expression. We also calculated correlation coefficients within CpG Islands 
located within gene bodies (i.e. >200 bp sequence within a gene body with > 60% 
CpGs). Ninety-seven percent (38/39) CpG sites within CpG islands located within gene 
bodies showed a negative correlation with gene expression. The genes that were 
differentially expression between Andeans and Europeans had more methylation sites 
with in regulatory regions with significant correlations between gene expression and 
DNA methylation than the altitude-associated DEGs (Fisher’s exact p=0.0242, Table 






We present here a genome scale analysis of mRNA expression and DNA 
methylation in villous placental tissue from 45 Bolivian individuals of primarily Andean or 
European ancestry from high versus low altitude. We have shown that (1) a total of 69 
genes were differentially expressed in the placenta in association with either altitude or 
ancestry, and (2) that epigenetic regulation of gene expression was more commonly 
associated with ancestry (Andean vs. European) as opposed to the environmental 
stressor of interest (altitude); and (3) how the DEGs might relate to the structural 
differences observed in the placentas themselves, which confer fetal growth advantages 
of Andean relative to European high-altitude inhabitants.  
Ancestry-Associated Differentially Expressed Genes 
Of the 34 ancestry-associated DEGs, 24 were more highly expressed in Andean 
compared to European placentas (Table 3.2, Figure 3.2, Supplementary Table 3.1). 
Among these ancestry-associated DEGs are several genes associated with 
inflammation including two inflammatory chemokines, c-c motif chemokine ligand 2 
(CCL2) and c-c motif chemokine ligand 3 like 3 (CCL3L3). The ancestry-associated 
increase in expression of inflammatory chemokine ligands, CCL2 and CCL3L3, would 
be expected to attract increased numbers of immune cells to the placenta (e.g. natural 
killer cells, macrophages, and monocytes), important in normal invasion and remodeling 
of the maternal-fetal interface (162). Previous work has shown increased pro-
inflammatory cytokines such as interleukin 1-beta in the circulation of pregnant women 
at high altitude regardless of ancestry(163, 164).  





angiogenic macrophages (Hofbauer cells), including CD163 molecule (CD163), 
lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), and major 
histocompatibility complex class 1 A (HLA-A), displayed higher expression levels in 
Andeans compared to Europeans. Hofbauer cells, i.e. placental macrophages, can 
secrete pro-angiogenic factors, which may contribute to the enhanced vascularity of the 
high-altitude Andean placenta and contribute to enhanced nutrient and gas exchange 
(165). We have shown that the placenta engages in increased glucose metabolism 
under high altitude conditions, and regulated by HIF-1 alpha (166, 167). HIF-1 alpha 
regulates expression of chemokines, including CCL2 and CCL3L3, which may result in 
increased angiogenesis (168). We therefore speculate that the genes we have identified 
related to the innate immune response may be permissive for the greater angiogenesis 
that we and others have observed in Andean placentas at high altitude (163).  
We tested for differential expression between those of Andean descent and 
those of European descent residing at high altitude and found that thirteen of the 
ancestry associated differentially expressed genes were differentially expressed 
between Andeans and Europeans residing at high altitude. Among those thirteen genes 
are CD163, LYVE1, CPVL, STC1, Coagulation Factor XIII A Chain (F13A1), 
LY6/PLAUR Domain Containing 3 (LYPD3), are all involved in angiogenesis, whether it 
be through recruitment of Hofbauer cells, or promoting invasion of the blood vessels. In 
contrast, there are zero genes that are differentially expressed between Andeans and 
Europeans residing at low altitude. This suggests that increased angiogenesis may be 
one of the factors that may be allowing native Andeans to healthier birth weights at high 





Andean women had a robust, altitude-associated increase in placental capillary 
surface area, length and volume, despite general similarity in placental weight and 
volume across the 4 groups. Increases in these functional parameters were 19-71% 
greater in Andean than European placentas for the same vascular variables. 
Functionally, one would expect greater capillary surface area and length to be 
associated with increased maternal-fetal nutrient transport and gas diffusion, whilst 
volume might be expected to relate to blood flow. We have no direct measures of 
diffusion, although extensive analysis of fetal blood gas parameters and oxygen delivery 
suggested the Andean fetus is advantaged relative to the European migrants (129). At 
the same time, and in these same pregnancies, we showed greater umbilical venous 
blood flow in the Andean vs. European fetus at high altitude, which may be related to 
their greater capillary volume (129). These data indicate a pronounced Andean 
advantage in the placental structural response to the chronic hypoxia of high altitude, 
centered on angiogenesis, and consistent with many of the ancestry-associated DEGs. 
We tested for correlation between gene expression levels ancestry associated DEGs 
and capillary volume and found that two genes had nominally significant correlations (p 
< 0.01). NAPRT has a nominal p-value of 0.004 and a Pearson correlation (r) of  
-0.435. This suggests that as expression levels of NAPRT decreases, resulting in 
decreased NAD+ and increased NADH, capillary volume increases (169). ATP2C2 has 
a nominal p-value of 0.0095 and has an R-value of 0.40 suggesting that increased 







Altitude-Associated Differentially Expressed Genes  
Of the 36 altitude-associated DEGs, 10 DEGs had lower expression levels at 
high altitude compared to low altitude (Table 3.3). Three of those genes, fos proto-
oncogene (FOS), fosb proto-oncogene (FOSB), and jun proto-oncogene (JUN) had the 
greatest negative fold-change in high altitude placentas. These genes are part of the 
activator protein 1 (AP-1) transcription factor complex. The AP-1 complex is a family of 
transcription factors formed by the dimerization of products from the FOS and JUN gene 
families (170). AP-1 transcription factors regulate the expression of genes involved in 
cell proliferation, cell death, and cellular transformation (171). This is consistent with 
molecular analyses addressing regulation of the cell cycle and apoptosis under in vivo 
(preeclampsia, IUGR, altitude) and in vitro low oxygen conditions (172-175). Previous 
studies have found an increase in cytotrophoblasts in high altitude placenta (176, 177), 
interpreted as hypoxia-induced proliferation. However, molecular data supports the 
excess cytotrophoblast cells are there due to a reduced rate of cytotrophoblast fusion 
into the syncytium. In essence syncytialization is delayed or slowed and apoptotic 
stimuli are diminished in the high altitude placenta. 
Decreased expression levels of genes forming the AP-1 transcription factor 
complex may indicate that there is less AP-1 transcription factor available to bind to its 
target genes. The reduction in expression levels of four AP-1 target genes at high 
altitude supports the idea that there may be less availability of the AP-1 transcription 
factor. These four genes include early growth response 1 (EGR1), olfactomedin like 3 
(OLFML3), regulator of G protein signaling (RGS1) and immediate early response 3 





decreased expression may result in reduced cell proliferation (178-181). The reduced 
cell proliferation may also contribute to reduced cytotrophoblast fusion into the 
syncytium (182, 183). 
Prior studies of gene expression in Tibetans and Andeans implicate the HIF 
pathway as a critical target of natural selection, and hence these pathways were 
examined carefully in this study (79, 184). The altitude associated DEGs include genes 
involved in the response to hypoxia and the induction of the hypoxia-inducible factor 
(HIF) pathway. DEGs associated with hypoxia and the HIF pathway show higher gene 
expression among residents of high vs. low altitude. The DEGs associated or induced 
by HIF induction with higher expression at high altitude include family with sequence 
similarity 46 member C (FAM46C), solute carrier family 4 member 1 (Diego blood 
group) (SLC4A1), and alpha hemoglobin stabilizing protein (AHSP) (Figure 3.1, Table 
3.3) (185-187). We have previously shown increased HIF-1 alpha gene expression, 
protein levels, and increases in the products of HIF’s target genes in placentas of non-
indigenous peoples residing at high altitude (188, 189). Placental gene expression for 
HIF-1 alpha (HIF1A), HIF-2 alpha (EPAS1), and HIF-3 alpha (HIF3A) in this study 
demonstrated low total variance (σ2 < 0.1186) and therefore were not subject to 
genome wide hypothesis testing. To determine if the three hypoxia inducible factors are 
differentially expressed regardless of low variance we tested these probes using a two-
way ANCOVA. There was greater expression of the HIF-3 alpha gene product among 
Andeans compared to Europeans regardless of altitude (p=0.01). We also found that 
there was greater HIF-1 alpha gene expression among Europeans vs. Andeans residing 





nominal p-value would hold up to the multiple hypothesis testing required in genome 
wide hypothesis testing, but this observation illustrates an interesting point. Several of 
the HIF-3alpha isoforms can attenuate HIF-1alpha binding to HREs in target genes 
(190, 191) and thereby modulate HIF-1alpha-dependent gene transcription. Studies of 
gene expression from leukocytes of Tibetans and Andeans indicate natural selection 
has favored variants of genes in the HIF-pathway that would be expected to lower the 
pO2 at which a HIF response is stimulated. This appears counter-intuitive unless one 
posits that this lowered threshold for stimulation of a HIF response contributes to 
maintenance of sea-level values for some physiological parameters, despite the high 
altitude environment, which is as good a measure of adaptation as any other (79, 184, 
192). That HIF-3alpha can attenuate HIF-1alpha target gene transcription and is 
elevated in placentas of Andeans regardless of altitude suggests it may act to further 
‘fine-tune’ HIF-1alpha responses. Given that vascularity in low altitude Europeans and 
Andeans is similar, these differences in HIF-related gene expression at high altitude 
begs the question of whether the increased HIF-3alpha and relatively lower, but still 
elevated, HIF-1alpha levels plays a role in the Andean advantage in placental vascular 
response to high altitude hypoxia (191) .  
Correlation between Genes that were Differentially Expressed Associated with 
Altitude or Ancestry and Methylation Patterns  
There were more ancestry-associated DEGs (n=17) that correlated with DNA 
methylation than altitude-associated DEGs (n=8, Table 3.4, Supplementary Table 3.3). 
This significant difference (Fisher’s exact p = 0.0242) supports our hypothesis that 





methylation changes can be introduced within a population at a faster rate than gene 
expression differences due to evolutionary selection for extant or new sequence 
polymorphisms (193). Placental DNA methylation would be favored over just sequence 
variation in a subset of genes as a readily modifiable way to alter gene expression 
without inducing a permanent genetic change in the germ cell line. An example of this 
would be if a sequence variant occurred at a CpG site that would change the CpG site, 
which is most likely to be methylated to a CpA. The G/A variant would there for affect 
DNA methylation. However change in sequence would take generations to become 
fixed where as DNA methylation would not take quite as long. This has been recognized 
in the obstetric literature (194). It is one additional way in which phenotypic plasticity, 
which is amply well documented among Andeans in quantifiable traits such as chest 
dimensions and lung volumes, is favored over genetic changes that would be 
permanent. 
It is well known that hypermethylation in the promoter region of genes typically 
results in lower gene expression resulting in an inverse correlation between DNA 
methylation and gene expression (195). The inverse correlation is likely due to DNA 
methylation blocking the binding of transcription factors to their respective binding sites 
(196). We have shown that among our DEGs, 72% (28/39) of methylation probes 
located within promoter regions had methylation values that were inversely correlated 
with gene expression with the remaining 28% (11/39) of promoter methylation sites 
having a positive correlation. We also found negative correlations between gene 
expression levels and DNA methylation within 97% (37/38) of the methylation probes 





islands may be acting as alternative promoters since CpG islands are typically located 
within promoter regions (197, 198). Transcription at alternative promoters may lead to 
isoforms that are unique to either an ancestral group or individuals exposed to an 
environment such as high altitude (199, 200). The use of intragenic CpG islands as 
tissue specific alternative promoters has been among cells that are part of the 
hematopoietic steam cell lineages as different cell types have different methylation 
patterns within CpG islands (200). 
In contrast to DNA methylation in promoters and CpG islands within gene bodies 
(i.e. introns and exons), increased DNA methylation within non-CpG island gene bodies 
is increasingly becoming associated with increased mRNA abundance and a positive 
correlation between gene expression and DNA methylation within the gene body (201). 
However, our results show only 57% (25/43) of the methylation sites within the gene 
body, excluding those within CpG islands, had methylation values that correlated 
positively with gene expression. All of the 25 DNA methylation sites that had a positive 
correlation between gene body DNA methylation and gene expression were associated 
with ancestry associated DEGs. This suggests that 43% of non-CpG island gene body 
DNA methylation may be acting in a similar fashion to promoter region methylation 
(195). The genes we found that had decreased promoter methylation and consequently 
higher gene expression among Andeans, are associated with inflammation and pro-
angiogenic macrophages. Those ancestry-associated DEGs with decreased promoter 
methylation include carboxypeptidase, vitellogenic-like (CPVL), lymphatic vessel 
endothelial hyaluronan receptor 1 (LYVE1), prolyl 3-hydroxylase 2 (LEPREL1) and N-





to the increased angiogenesis in Andeans compared with Europeans placentas at high 
altitude. Gene expression differences associated with altitude may be less dependent 
on epigenetic mechanisms and more dependent on the availability of transcription 
factors (e.g. AP-1 binding), or sequence variation favored by natural selection because 
we found less altitude associated DEGs correlated with DNA methylation. Seven 
altitude-associated DEGs had expression levels that correlated significantly with DNA 
methylation including genes involved in cellular and membrane repair such as gliomedin 
(GLDN) and dysferlin (DYSF). Both genes have a negative correlation between gene 
expression values and promoter DNA methylation suggesting that those residing at high 
altitude have decreased promoter methylation being associated with the increased gene 
expression compared to the low altitude populations. 
This is the first study, to our knowledge, that investigates how placental gene 
expression differs among distinct populations of different biogeographic ancestry, which 
gene expression differences may be regulated by DNA methylation, and how these 
mechanisms may differ in the setting of reduced oxygen tension. It is also the first to 
consider these differences in relation to structural/functional differences in the target 
organ. It differs from prior studies that have identified polymorphisms found in DNA from 
leukocytes, which are likely unrepresentative of tissue or cell-specific gene expression 
patterns (79, 83). The gene variants identified in those studies have not yet been 
examined in a functional context nor have pre- or post-translational modifications to the 
proteins encoded by the genes of interest been tested. Moreover, DEGs based on 
functional tissues of impact on reproductive outcomes are likely not reflected in DEGs 





more likely to reflect short-term, rather than long term, reproductively important 
outcomes. The study reported here provides insight into how DNA methylation may be 
regulating gene expression in the placental tissue of Andeans, which, unlike Tibetans, 
may have significant exposure to low altitude environments through culture and 
commerce. It suggests that Andean placentas may be adapting to the high altitude 
environment, seen by a preservation in birth weight, through epigenetic modifications as 
opposed to sequence variation. This work supports the well known idea that ancestry 
has a great impact on DNA methylation because the ancestral background has been 
shaped by the different environments, which the different ancestries were exposed to.  
For example there are ancestry specific DNA methylation sites between Europeans and 
African Americans that may affect how they metabolism vitamin D which include areas 
on various tumor suppressor genes that may be passed from the mother to the child 
(207). Also in a study comparing cancer patients they found ancestry specific DNA 
methylation within intergenic regions between individuals of African, European, and 
Asian ancestry (208).  
A major limitation of this study is the small sample size, which restricts the power 
of our analysis by limiting the number of probes that would be significant after adjusting 
for multiple hypothesis testing. To account for this, we focused our analysis on only the 
top 5% most variable probes. Recent literature on altitude-associated genetic variation 
revealed polymorphisms in genes related to the hypoxia-inducible factor nuclear 
transcription family of genes (i.e. HIF1A, EPAS1, HIF3A) between high and low altitude 
populations (79, 209). The fact that we did not see differential expression in the same 





the fact that the placenta of adapted individuals at high altitude receives the same 
amount of oxygen as the low altitude placenta, albeit at markedly lowered blood flow 
(129). Other limitations include the range of RIN scores used in this study, which may 
affect the ability of the respective cDNA to hybridize to the microarray chip affecting 
expression levels. Studies asking whether there has been natural selection of genetic 
polymorphisms or novel sequence variants in high altitude populations are limited to 
leukocytes. In our study, HIF-related genes did not achieve the level of statistical 
significance required for further exploration. Larger sample sizes may remedy this. 
Finally, ancestry differences may have affected hybridization, as the microarray chips 
were designed using primarily European sequences.   
Conclusion: 
We have identified differences in gene expression within the term human 
placenta in response to two different factors, altitude (high vs. low) and biogeographic 
ancestry (Andean vs. European). We have attempted to link the gene expression 
changes to differences in placental structure and consequently birth weights at high 
altitude. The approach is warranted because of the strong correlation between placental 
size and structure with pregnancy outcomes such as birth weight, preeclampsia and 
IUGR (210-213). We found that the ancestry-related expression differences are related 
to inflammatory processes and angiogenesis. By contrast, the altitude-related 
expression differences are more-closely linked to changes in the AP-1 transcription 






Lastly, we have shown that DNA methylation appears to regulate the ancestry-
associated DEGs more than the altitude-associated DEGs. Taken together, the results 
suggest that the phenotypic plasticity conferred by methylation over sequence variation 
in genetic polymorphisms is a preferred evolutionary strategy. Epigenetic changes, 
because they can be environmentally induced and presumably absent or reversed in an 
alternative environment, permit greater flexibility in  the face of stressful/changeable 
environments. These data also support that organ-specific or target tissue evaluation of 
gene expression is required in the assessment of genetic adaptation to environmental 
stress.  
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Figure 3.1 Heat map of Z-scores for each altitude-associated differentially 
expressed gene 
 
Figure 3.1: Heat map of Z-scores for each altitude-associated differentially 
expressed gene: Z-scores calculated from gene expression of each altitude-associated 
differentially expressed gene. The blue pixels represent negative z-scores (i.e. 
expression level for that sample is less than the mean expression) and the yellow pixels 
represent samples with positive z-scores (i.e. expression levels for that sample is 
greater than the mean expression level). A gene was considered to be differentially 
expressed with a FDR<0.1 and an absolute fold change≥1.25 between individuals 



























































Figure 3.2 Heat map of Z-scores for each ancestry-associated differentially 
expressed gene 
 
Figure 3.2: Heat map of Z-scores for each ancestry-associated differentially 
expressed genes 
Z-scores calculated from gene expression of each ancestry-associated differentially 
expressed gene. The blue pixels represent negative z-scores (I.e. expression level for 
that sample is less than the mean expression) and the yellow pixels represent samples 
with positive z-scores (i.e. expression levels for that sample is greater than the mean 
expression level). A gene was considered to be differentially expressed with a FDR<0.1 




























































Table 3.1: Clinical data for placenta samples. A 2-way ANOVA was used with 
altitude and ancestry as the independent variables. An interaction term with P < 
0.05 indicates that the phenotype associated with the combination of altitude and 
ancestry differs significantly between biogeographic ancestry groups. For 
example, the increase in placental capillary volume due to altitude is greater 



















N 10 11 12 12    
Maternal 
age 




23.9±2.9 23.9±3.0 26.2±3.5 22.8±4.3 0.953 0.032 0.437 
Gravidity 4.4±3.7 1.6±0.9 3.8±2.5 2.3±1.3 0.900 0.004 0.400 
Parity 1.9±1.7 0.5±0.5 2.3±2.5 1.0±1.0 0.330 0.009+ 0.843 
Neonatal 
Sex 
M=6, F=4 M=4, F=7 M=7, F=5 M= 5,  
F= 7 






Table 3.1 (cont.) 
 


































































Table 3.2: Fold change of Illumina HT12-v4 gene expression microarray probes 
that are significantly differentially expressed (FDR > 0.1) as a function of ancestry 
Probe ID Gene Symbol Fold Change FDR 
ILMN_1710752 NAPRT -2.03 0.011 
ILMN_1740586 PLA2G2A -1.7 0.072 
ILMN_2173294 THNSL2 -1.65 0.001 
ILMN_3248833 RPS26 -1.64 0.001 
ILMN_3299955 RPS26 -1.56 0.001 
ILMN_1739605 LYPD3 -1.56 0.001 
ILMN_2209027 RPS26 -1.54 0.001 
ILMN_2310703 RPS26 -1.52 0.004 
ILMN_1715169 HLA-DRB1 -1.48 0.092 
ILMN_1685580 CBLB -1.47 0.011 
ILMN_2411282 QSOX1 -1.42 0.011 
ILMN_1687035 ADAMTSL4 -1.32 0.035 
ILMN_1762294 ADAMTSL4 -1.3 0.053 
ILMN_1691717 RHBDF2 1.26 0.051 
ILMN_1749403 TSPAN33 1.27 0.035 
ILMN_1772359 LAPTM5 1.28 0.071 
ILMN_1733270 CD163 1.28 0.064 
ILMN_1717163 F13A1 1.29 0.094 
ILMN_1683792 LAP3 1.29 0.054 
ILMN_1721035 MS4A6A 1.31 0.094 
ILMN_1785413 ATP2C2 1.31 0.047 
ILMN_2352023 DSTYK 1.32 0.094 
ILMN_1657373 LEPREL1 1.33 0.071 
ILMN_1808114 LYVE1 1.34 0.099 
ILMN_1740024 NAALAD2 1.35 0.051 
ILMN_1670490 PDPN 1.36 0.094 
ILMN_2203950 HLA-A 1.38 0.094 
ILMN_2200659 SNHG5 1.38 0.088 
ILMN_1808245 SBSPON 1.38 0.072 
ILMN_1662419 COX7A1 1.39 0.072 
ILMN_1682928 CPVL 1.39 0.015 
ILMN_2379599 CD163 1.4 0.027 
ILMN_2130441 HLA-H 1.4 0.086 
ILMN_2186806 HLA-A 1.41 0.060 
ILMN_1722622 CD163 1.41 0.035 
ILMN_2400759 CPVL 1.42 0.011 
ILMN_1797875 ALOX5AP 1.42 0.094 
ILMN_1758164 STC1 1.43 0.004 
ILMN_1772459 RPS23 1.44 0.010 
 
 






Table 3.2 (cont.) 
ILMN_1776967 DNAAF1 1.46 0.089 
ILMN_2105573 CCL3L3 1.53 0.099 








Table 3.3: Fold change of Illumina HT12-v4 gene expression microarray probes 
that are significantly differentially expressed (FDR < 0.1) associated with altitude.  
Probe ID Gene Symbol Fold Change  FDR 
ILMN_1669523 FOS -2.04 0.045 
ILMN_1762899 EGR1 -1.9 0.055 
ILMN_1751607 FOSB -1.63 0.080 
ILMN_1806023 JUN -1.56 0.068 
ILMN_1892403 SNORD13 -1.47 0.068 
ILMN_2242463 CTSC -1.35 0.098 
ILMN_1778977 TYROBP -1.31 0.084 
ILMN_1727532 OLFML3 -1.3 0.069 
ILMN_1682928 CPVL -1.3 0.075 
ILMN_1656011 RGS1 -1.28 0.069 
ILMN_1682717 IER3 -1.27 0.075 
ILMN_1812073 ATP6V1B1 -1.25 0.075 
ILMN_2075927 STK40 1.26 0.068 
ILMN_1727589 SULT2B1 1.29 0.055 
ILMN_1763749 GUCA2A 1.29 0.075 
ILMN_1689817 LCOR 1.29 0.098 
ILMN_1772809 SLC4A1 1.29 0.055 
ILMN_1677684 BTBD16 1.3 0.080 
ILMN_1713751 ADAM19 1.3 0.069 
ILMN_2205963 C10orf54 1.31 0.068 
ILMN_1784333 SECISBP2L 1.32 0.055 
ILMN_2376502 RHOBTB1 1.32 0.070 
ILMN_1765332 TIMM10 1.33 0.069 
ILMN_1695187 GYPE 1.34 0.068 
ILMN_1746578 SLC23A2 1.35 0.055 
ILMN_1717262 PROCR 1.35 0.069 
ILMN_1695157 CA4 1.37 0.069 
ILMN_1810420 DYSF 1.38 0.001 
ILMN_1740604 RAB11FIP5 1.4 0.069 
ILMN_1763666 ALDH3B2 1.42 0.067 
ILMN_1759155 IFIT1B 1.42 0.068 
ILMN_1707734 NNAT 1.43 0.075 
ILMN_1704376 GLDN 1.44 0.075 
ILMN_1696512 AHSP 1.52 0.068 
ILMN_1713266 FAM46C 1.57 0.068 









Table 3.4: Table of the number of genes that may be regulated by DNA 
methylation or not regulated by DNA methylation among altitude and ancestry 
associated differentially expressed genes. 
  Ancestry Altitude 
Regulated by DNA methylation 17 8 











































Supplementary Table 3.1: Tables of differentially expressed genes associated with 
altitude and/or ancestry. 






















Supplementary Table 3.2: Validation of gene expression microarray by qRT-PCR 









FOS Hs99999140_m1 0.75 <0.0001 Altitude 0.0043 
NAPRT Hs00292993_m1 0.56 0.0004 Ancestry 0.043 
PLA2G2A Hs00179898_m1 0.51 0.0012 Ancestry 0.91 
LYVE1 Hs00272659_m1 0.47 0.003 Ancestry 0.095 
STC1 Hs00174970_m1 0.46 0.004 Ancestry 0.099 




















Supplementary Table 3.3: Results of the Pearson’s correlation test between DNA 
methylation and gene expression 






















Supplementary Figure 3.1: Scatterplot of variance of Illumina HT12v4 gene 
expression microarray probes 
 
 
Supplementary Figure 3.1: Scatterplot of variance of Illumina HT12v4 gene 


























Supplementary Figure 3.2: Correlation of gene expression with methylation values of 
differentially expressed genes 
For supplementary Figure 3.2 please use the provided link: 
https://www.biorxiv.org/highwire/filestream/113157/field_highwire_adjunct_files/4/26197
4-5.jpg 
Supplementary Figure 3.2: Differentially expressed genes with at least one 
methylation site that significantly correlates with gene expression values sorted by its 
location with the right most sites being located on chromosome 1. The green circles 
represent CpG sites located within the gene body. The orange circle represents CpG 
sites located within the promoter region. The purple circles represent CpG sites that are 
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Abstract: 
The placenta mediates fetal growth by acting as a substrate for nutrient 
exchange between the mother and the fetus. Environmental factors such as altitude 
have been shown to result in reduced maternal-fetal exchange leading to reduced birth 
weight. To determine if differences in gene expression maybe contributing to 
physiological differences between individuals at high and low altitude, we tested for 
differences in DNA methylation between Andean and European placental samples from 
La Paz (~3,600m) and Santa Cruz, Bolivia (~400m). Among altitude associated 
differentially expressed genes, we previously noticed that one gene, dysferlin (DYSF) 
had higher expression among residents at high altitude compared to low altitude. DYSF 






methylation that correspond to individual genotypes (A/A < A/G < G/G methylation). We 
tested for natural selection by sequencing a ~2.5 kb fragment that includes the above 
DYSF variant from 90 Bolivian samples and compare with 1000 genome data. We 
found that balancing selection (Tajima’s D=2.37) was acting on this fragment among 
Andeans regardless of altitude. This suggests that balancing selection acting on 
dysferlin is altering DNA methylation patterns. Also, preservation of both the Adenine 
(A) and Guanine (G) alleles may aide Andeans in moving from high to low altitude and 
vise versa. 
Introduction: 
Natural selection is one of the mechanisms that has been shown to contribute to 
differences between populations at both the genotypic and phenotypic level (214). The 
two major types of natural selection that cause changes in allele frequencies are 
directional selection and balancing selection. A site under directional selection has one 
allele frequency that is greater than the other suggesting the more frequent allele may 
be more beneficial than the less frequent allele (215). One example of directional 
selection, specifically positive selection, is seen in relation to lactase persistence 
among individuals residing in arid regions (139); the authors showed the three major 
variants within the lactase gene show positive selection that favor better absorption of 
nutrients and water from milk in regions where water is less available. A site 
experiencing balancing selection has two alleles of roughly equal frequency suggesting 
both alleles may be beneficial (216). A well-known example of balancing selection is 
seen in those individuals who are heterozygotes for the sickle cell allele associated 






healthy disk shape cell but also show some resistance toward malaria (217). In 
opposition to natural selection, if the change in allele frequency occurred randomly in a 
population, that population is experiencing genetic drift (219). One common instance 
where genetic drift occurs is when a population migrates, typically reducing in size 
(220). This reduction in population size can cause a shift in allele frequency, not 
related to natural selection. 
The high altitude environment has been shown to act as a selective pressure 
resulting in variant changes in different regions of the human genome potentially 
leading to physiological adaptations. Early studies among Andeans residing at high 
altitude found signatures of positive selection in genes associated with the response to 
hypoxia including endothelial PAS domain protein 1 and Egl-9 family hypoxia inducible 
factor 1 (221). In addition to pervious studies, our prior work found genes associated 
with cell fusion and proliferation were differentially expressed between individuals 
residing at high and low altitude many of which showed differences in DNA 
methylation. In this prior study, we found 8 out of 36 altitude associated differentially 
expressed genes had significant correlation between gene expression and DNA 
methylation (222). One of the altitude-associated differentially expressed genes that 
showed differences in DNA methylation is dysferlin (DYSF). DYSF is a large gene 
comprised of roughly 230 Kb with more than 50 coding exons. Within the third intron of 
the gene dysferlin, there is a single nucleotide polymorphism (SNP) that could change 
a CpG site to a CpA, which is less likely to be methylated (223). DYSF encodes a 
membrane bound protein associated with calcium regulated membrane repair (224). 






formed by the fusion of mononucleated cells (225-227) (Figure 4.1). In the placenta, 
dysferlin is expressed in the apical membrane of the multi-nucleated 
syncytiotrophoblast and is induced when the mononucleated cytotrophoblast fuse 
during syncytiotrophoblast formation and repair (228).  
The goal of this work was to determine if natural selection, induced by the high 
altitude environment, was acting on dysferlin leading to a change in allele frequency 
affecting DNA methylation and gene expression. To do this we tested if the population 
was in accordance with Hardy-Weinberg equilibrium and distinguished between 
selection and genetic drift by estimating Tajima’s D. We found that those individuals 
residing at high altitude show a signature of balancing selection suggesting that two 
alleles may be beneficial. 
Materials and Methods: 
Samples 
Term placentas from 96 Bolivian individuals were collected from La Paz, Bolivia 
(3,600m) and Santa Cruz, Bolivia (400m). The placentas were from healthy individuals 
undiagnosed with preeclampsia or intrauterine growth restrictions and were delivered 
through caesarian section. All women gave written informed consent to protocols 
approved by the Bolivian National Bioethics Committee, the San Andreas Mayor 
University, Instituto Boliviano de Biologia de Altura Consejo Tecnico, and the USA 








Identification of Differentially Methylated Sites Associated with Differential Gene 
Expression 
 DNA was extracted from the villous tissue of term placenta and used for DNA 
methylation analysis and SNP genotyping. DNA methylation data was generated using 
the HM450k methylation microarray chips using previously described methods (222). 
Validation was performed using 350 ng of placental DNA from 8 individuals from our 
sample groups as well as high and low methylation controls (Zymo Research, Irvine, 
CA) were bisulfite converted using the Zymo EZ DNA Methylation-Gold Kit (Zymo 
Research, Irvine, CA). The samples chosen were those that had methylation microarray 
data and provided an even representation of each genotype. Primers developed for this 
study were designed using the PyroMark Q24 Assay Design Software 2.0 (Qiagen, 
Hilden, Germany)(Supplementary Table 4.1). The desired fragment was 60 bp 
containing three different CpG sites and amplified using the Qiagen PyroMark PCR 
master mix and manufacture suggested protocol (Supplementary Table 4.1). 
Pyrosequencing was performed on the PyroMarkQ24 Advanced using a sequencing 
primer (Supplementary Table 4.1) as well as the standard PyroMarkQ24 Advanced 
reagents and protocol. 
Single Nucleotide Polymorphism Genotyping  
We genotyped SNP rs10166384 within dysferlin (DYSF) using DNA from term 
placentas of 96 individuals (48 Andean, 48 European) collected from La Paz, Bolivia 
(3,600m) and Santa Cruz, Bolivia (400m) including the 45 individuals from our prior 
study (222).  We genotyped SNP rs10166384 in 96 individuals using a TaqMan SNP 






with rs10166384 (A/G) being located at the 26th base. The adenine was labeled with 
VIC and the Guanine was labeled with FAM. The assay was run on an ABI 7500 
(Applied Biosystems, CA). The run conditions used were those standard to the TaqMan 
SNP genotyping assay provided in the ABI 7500 manual. We then calculated the allele 
frequencies of the A and G allele for each of the four sample populations measured by 
the Taqman genotyping. Allele frequencies were calculated for each sample group to 
determine if the environment of high altitude provided a selective pressure on this site. 
We then tested to see if the proportion of the three genotypes were what one would 
expect for a population within Hardy-Weinberg equilibrium. When a population is within 
Hardy-Weinberg equilibrium it is assumed to have no selection, no mutation, no 
migration, a large population size, and random mating.  χ2 analysis was performed to 
determine if the proportion of genotypes in each of the four sample groups were 
significantly out of Hardy-Weinberg equilibrium (p<0.05).  
Detecting Natural Selection 
To determine if natural selection was acting on our SNP of interest (rs10166384) we 
amplified a ~2500 base pair region using polymerase chain reaction from DNA of 96 
individuals (Supplementary Table 4.1). PCR products were purified using the QIAquick 
pcr purification kit (Qiagen, Hilden, Germany). Between 30 and 50 µg of each PCR 
product was sequenced at the UIUC core sequencing center (Urbana, IL). The 
sequences generated from each primer were aligned using Sequencher (Gene Codes, 
Ann Arbor, MI). The complete sequences from each sample were then aligned to each 
other using the ClustalW (229) algorithm implemented in MEGA version 6.06 (230). 






SNP-sites (231). We calculated allele frequencies for each polymorphism, determined if 
each subpopulation was in Hardy-Weinberg equilibrium, and calculated Tajima’s D for 
all SNPs with a minor allele > 0.05 using vcftools version 0.1.13 (232, 233). 
Results: 
 Through analyzing DNA methylation patterns of genes we previously found to be 
differentially expressed (222), we found a probe (cg09829645) within the third intron of 
dysferlin that had three distinct levels of DNA methylation (Figure 4.2a). One group 
showed hypomethylation, low levels of DNA methylation (M=-5.01±0.67), one group 
was hypermethylated, high levels of DNA methylation (M=1.97±0.36), and one group 
was hemimethylated with median DNA methylation levels (M=-0.11±0.49). This probe 
was located in the same position as a polymorphism (rs10166384),which can either, be 
a Guanine (G) or an Adenine (A) nucleotide. After genotyping this site in 96 individuals 
of Andean and European descent from high and low altitude, we found that the levels of 
DNA methylation tended to correspond to the three different genotypes possible at 
rs10166384 (Figure 4.2b). Those that were homozygous for the A allele (A/A) had on 
average the lowest levels of DNA methylation (M=-4.21±1.96), those that there 
homozygous for the G allele (G/G) had on average the highest levels of DNA 
methylation (M=1.41±0.97), and those that were heterozygous (A/G) had methylation 
values that fell in between the two homozygous groups ((M=-0.51±2.06) (Figure 4.2b). 
The genotype specific DNA methylation was confirmed through pyrosequencing a 
region containing rs10166384 in a subset of individuals for which we have methylation 






Individuals residing at high altitude were more likely to have the A allele and 
those residing at low altitude were more likely to have the G allele. The allele 
frequencies varied depending on ancestry as well. Europeans residing at high altitude 
had an A allele frequency of 0.64 while Europeans residing at low altitude had an A 
allele frequency of 0.38 (Table 4.1). Europeans residing at high altitude had a greater 
number of individuals that were homozygous for the A allele compared to Europeans 
residing at low altitude (Table 4.1). We noticed that those of primarily European descent 
had a negative correlation between the A allele frequency and the percentage of Native 
American admixture, previously estimated in Zamudio et. al. (130). Europeans residing 
at high altitude had on average 26% Native American admixture and an A allele 
frequency of 0.64 while low altitude Europeans had more native admixture (~33%) and 
a lower frequency of the A allele of 0.38 (Table 4.1). Among Native Andeans, there was 
a less drastic change between high and low altitude Andeans with A allele frequencies 
of 0.54 and 0.46 respectively. There was also much less admixture among the Andean 
populations compared to the European populations. The Andeans residing at high 
altitude had ~3% European admixture and those Andeans residing at low altitude had 
~5% European admixture. 
We tested to see if natural selection induced by the high altitude environment 
was contributing to the change in allele frequency at the location of SNP rs10166384 
causing a shift in DNA methylation. We tested to see if any of our four sample groups 
were out of Hardy-Weinberg equilibrium suggesting that the proportion of the genotypes 
are different then would be expected for a population not being influenced by selective 






that was significantly out of Hardy-Weinberg equilibrium  (χ2 = 5.916, p = 0.015). The 
high altitude Andeans had fewer heterozygotes then a population in accordance with 
Hardy-Weinberg equilibrium (Table 4.2). While the high altitude Andeans were the only 
population that was significantly out of Hardy-Weinberg equilibrium, the high altitude 
Europeans were only nominally significant for being out of Hardy-Weinberg equilibrium 
(χ2 = 3.711, p = 0.054), also having fewer heterozygotes then would be expected for a 
population in Hardy-Weinberg equilibrium. Lastly, both Andeans and Europeans 
residing at low altitude had genotype frequencies that were in accordance with Hardy-
Weinberg equilibrium.  
We then determined the if change in genotype proportions was influenced by 
directional selection, balancing selection, or random genetic drift by calculating Tajima’s 
on a 2.5kb region with six polymorphisms with had minor allele frequencies > 0.05 
(233). We found that the Andeans regardless of altitude had the highest estimated 
Tajima’s D value of 2.35 suggesting balancing selection or roughly equal frequencies of 
each alleles. Also, the Europeans regardless of altitude had a Tajima’s D of 1.86 also 
suggesting balancing selection. 
Discussion: 
Nucleotide Adaptation in Dysferlin 
 The variant rs10166384 (G/A) is located directly downstream of a cytosine causing 
a CpG site to potentially become a CpA site reducing the likelihood of DNA methylation 
within our four sample populations (234). rs10166384 is located within a TEAD4 
transcription factor binding site, involved in the formation of syncytial tissues including 






DNA methylation along transcription factor binding sites limits the binding of the TEAD4 
transcription factor to its binding site resulting in decreased DYSF gene expression.  We 
found that the A homozygotes had the lowest level of DNA methylation (Figure 4.2b). 
The G homozygotes had the highest levels of DNA methylation and likely decreased 
DYSF gene expression. The heterozygotes, having both an A and G allele, had 
methylation levels between the homozygous groups (Figure 4.2b). Reduced DYSF 
expression may result in reduced cytotrophoblast fusion and less effective 
syncytiotrophoblast fusion at high altitude (236).  Several pregnancy complications 
where hypoxia is a contributing factor such as preeclampsia and intrauterine growth 
restriction show decreased DYSF gene expression and problems with 
syncytiotrophoblast formation (237). 
 We compared allele frequencies across our four sample populations (high altitude 
Andeans, high altitude Europeans, low altitude Andeans, and low altitude Europeans) 
and found the populations with the highest A allele frequencies were of the high altitude 
European ancestry (A allele frequency =0.64). The higher A allele frequency 
corresponds with a decrease in methylation compared to low altitude Europeans (ΔM =-
2.62). Lower DNA methylation may contribute to the higher DYSF gene expression 
within the high altitude European population compared to the low altitude European 
population. The A allele is also more abundant among those individuals residing in 
Spain who were genotyped as part of the 1000 genomes project, suggesting that the A 
allele is the ancestral European allele. The high frequency of A alleles among 
Europeans residing at high altitude could be related to the fact that this study only 






more beneficial for the Europeans residing at high altitude because it may be linked to 
more effective DYSF transcription and more effecting cytotrophoblast fusion and 
syncytiotrophoblast repair increasing the chance of a healthy pregnancy. We predict 
that if we were to genotype Europeans residing at high altitude who experienced 
problematic pregnancies we would see an increased G allele frequencies potentially 
related to less effective syncytiotrophoblast repair.  
 We compared allele frequencies of our sample populations to those of East Asian, 
European, and South American descent from the 1000 genome project (238) and found 
that allele frequencies of our Bolivian samples had allele frequencies that lie in between 
those of the East Asian and European 1000 genomes populations (Figure 4.3). We 
chose to look at the east Asian populations because they are the ancestral population 
for the Native Andeans as the east Asians crossed over the Bering strait land bridge 
being the first people to settle in Americas roughly 12,000 years ago (239). The East 
Asians that were part of the 1000 genomes project had G as the major allele for SNP 
rs10166384 with an average G allele frequency of 0.74. Apart from the East Asians, the 
European samples from the 1000 genomes had the A as the major allele at this site with 
an A allele frequency of 0.68. The fact that both the Andeans and Europeans residing in 
Bolivia had intermediate allele frequencies, having roughly equal allele frequencies of 
both the A and G allele suggests that there has been East Asian and European 
admixture resulting in the Andeans gaining more of the European A allele and the 
Europeans gaining more of the East Asian G allele (Figure 4.3). This suggests that the 
more generations Europeans have resided at high altitude the greater the chance that 






allele most frequent among East Asians, compared to the Europeans from the 1000 
genomes project causing them to become significantly out of Hardy-Weinberg 
equilibrium.  
 We found that the Native Americans residing at high altitude had genotype 
proportions that were significantly out of Hardy-Weinberg equilibrium (p=0.015). This 
suggests that over the ~12,000 years the Andeans have resided at high altitude the 
selective pressure of the environment has caused a shift in genotype proportions. This 
shift at rs10166384 may potentially allow the Andeans to utilize DNA methylation to alter 
DYSF expression as they shift between high and low altitude. We noticed that 
Europeans residing at high altitude are nominally out of Hardy-Weinberg equilibrium 
(p=0.054). This indicates that the selective pressure of high altitude may also be 
resulting in sequence level change at site rs10166384, however the Europeans have 
not resided at high altitude for enough generations to cause the population to be 
significantly out of Hardy-Weinberg equilibrium. We predict that after a few more 
generations at high altitude, rs10166384 will be significantly out of Hardy-Weinberg 
equilibrium in the high altitude European population. Those of European ancestry 
residing in Bolivia who had healthy pregnancies had a higher frequency of the A allele 
compared to the G allele resulting in decreased methylation through less CpG sites. 
The decreased methylation may lead to more effective TEAD4 binding and more 
effective transcription leading to increased DYSF expression. The increased expression 
of DYSF allows for better syncytiotrophoblast repair and fusion in response to the 






 Allele frequencies for the Andean and European populations regardless of ancestry 
had A and G allele frequencies of 0.5 suggesting that balancing selection is acting on 
and around variant rs10166384. This is supported by the positive Tajima’s D value of 
2.37 and 1.85 across Andean and European populations respectively. A significantly 
positive Tajima’s D (D > 1.80) indicates balancing selection suggesting that both the A 
and G allele maybe beneficial in the high altitude environment (233). Those possessing 
a G allele are more likely to be methylated limiting the binding of the TEAD4 
transcription factor resulting in decreased gene expression. Methylation at this site 
however may allow for more transient regulation of dysferlin allowing for a smoother 
transition between high and low altitude. Those that have the A allele maybe regulating 
gene expression by limiting the ability of this CpG site to be methylated potentially 
resulting in higher gene expression. Higher dysferlin gene expression may result in 
more effective syncytiotrophoblast repair in the high altitude environment increasing the 
likelihood of a successful pregnancy. The preservation of both the A and G alleles 
among native Andeans regardless of altitude suggests that both the ability to be 
methylated and regulating of transcription factor binding may aide the Andeans in giving 
births children with healthy birth weights regardless of what altitude they reside in at the 
time. 
Conclusion: 
 In this work, we identified a case where ancestry dependent natural selection may 
alter DNA methylation by changing the nucleotide sequence. In the gene dysferlin, we 
noticed a variant (rs10166384) located within a transcription factor-binding site that can 






altitude are likely to have decreased DNA methylation and higher dysferlin gene 
expression. The higher dysferlin gene expression is likely to contribute to more effective 
syncytiotrophoblast repair in response to the high altitude environment, which may lead 
to more successful pregnancies at high altitude. Those with the G allele are more likely 
to have DNA methylation along the transcription factor-binding site and decreased gene 
expression. This may be advantageous among those of Andean ancestry because it 
may allow them a way to easily modify gene expression as they move between high 
and low altitude. As native Andeans move to high altitude the DNA methylation may be 
removed increasing dysferlin gene expression allowing for increased membrane repair 




















Figure 4.1: Drawing of a villous cross-section of a human placenta 
 
Figure 4.1: Figure 4.1 is a schematic of a cross-section of the villous tissue of the 
human placenta. The outer layer comprised of multi-nucleated syncytiotrophoblast. The 
second layer is comprised of mononucleated cytotrophoblast, which fuse to form the 















Figure 4.2: Estimated genotypes based on methylation.  
 
 
Figure 4.2: Prediction and confirmation of genotype using DNA methylation status at 
methylation probe cg09829645 which is in the same location as variant rs10166384. 
Figure 4.2a shows three groups with different levels of DNA methylation at probe 
cg09829645, one group is hypomethylated, one group is hemimethylated, and one 
group is hypermethylated. Figure 4.2b shows the average methylation for the individual 
genotypes that are possible at the rs10166384 variant. Those with the AA genotype 
tend to have low levels of methylation, those with GG genotype tend to have high levels 
of DNA methylation and those with the AG genotype tend to have methylation levels 



































































Figure 4.3: Figure 4.3 shows the comparison of the G allele frequency among our 
Andean sample populations (red) to example 1000 genomes populations (black). AMR 
= Americans from the 1000 genomes project, AND = Native Andeans from Bolivia, EAS 
= East Asians from the 1000 genomes project, EUR = Europeans from the 1000 
























Table 4.1: Allele frequency and genotype proportions for site rs10166384 among 
the Bolivian samples as well as East Asian and European populations from the 
1000 genomes project 











CHB 0.28 0.72 0.08 0.60 0.32 
LE 0.38 0.62 0.10 0.36 0.54 
L 0.42 0.58 0.15 0.54 0.31 
LA 0.46 0.54 0.22 0.48 0.30 
A 0.50 0.50 0.28 0.45 0.27 
E 0.50 0.50 0.32 0.36 0.32 
HA 0.54 0.46 0.42 0.25 0.33 
H 0.59 0.41 0.46 0.26 0.28 
HE 0.64 0.36 0.49 0.39 0.12 




Table 4.1: Allele and genotype frequencies site rs10166384 for the Bolivian sample 
populations and representative east Asian (CHB) and European (IBS) populations, LE = 
Low Altitude Europeans, L = Low Altitude, LA = Low Altitude Andeans, A = Andeans, E 
= Europeans, HA = High Altitude Andeans, H = High Altitude, HE = High Altitude 
































DYSF_F1 ATGCCATCCCTGCATAGTGT 56.6 851 
DYSF_R1 AGCCTCCTGTGCCATCTTAG 
DYSF_F3 CCTGCTGGTAAGTGAGGAGT 56 2051 
DYSF_R4 GGCCAGCTAACCATAGAAAA 
DYSF_F5 CCCCAAACCTCCATGATTTA 53 675 
DYSF_R5 CATAATCCCCATGTGCTGTG 







   
DYSF_Pyro_S1 GTTTGAATAATTTTTGTGGG   
 
 
Supplementary Table 4.1: Table of primers used for PCR, Sanger sequencing and 
pyrosequencing. Primers DYSF_F1, DYSF_R1, DYSF_F3, DYSF_R4, DYSF_F5,  and 
DYSF_R5 were primer sets used for the detection of natural selection. Primers 
DYSF_PyroF1 and DYSF_PyroR1-Biotin were primers used on bisulfite converted DNA 
to generate the amplicon used for the vaiidation of the methylation array. Primer 































Supplementary Figure 4.1: Correlation of 450k methylation with pyrosequencing 
Correlation of beta values generated using the Illumina 450k methylation microarray (x-
axis) and percent methylation calculated from the pyrosequencing  analysis. The gray 







CHAPTER 5: DISCUSSION 
In this dissertation I (along with my colleagues) discussed how placental gene 
expression differences among Andeans and Europeans may contribute to physiological 
differences seen among Andeans and Europeans residing at high altitude. In chapter 
two I discussed how increased expression of genes associated with placental 
macrophages (i.e. Hofbauer cells), may have contributed to increased capillary surface 
area among native Andeans residing at high altitude compared to Europeans residing in 
the same location (222). Along with the gene expression differences between Andean 
and Europeans, we noticed that those residing at high altitude regardless of ancestry, 
had decreased expression of genes associated with the AP-1 transcription factor family 
including JUN and FOS. The decrease expression of genes involved in the AP-1 
transcription factor family and its targets suggests decreased cell fusion and less cell 
proliferation (240). We also tested for correlation between gene expression and DNA 
methylation to determine if DNA methylation explained a greater subset of differential 
gene expression among the altitude or ancestry associated differentially expressed 
genes. We found that more ancestry associated differentially expressed genes had a 
significant correlation between gene expression values and DNA methylation values. 
The more ancestry associated genes with a significant correlation between gene 
expression and DNA methylation suggests that the Andeans may be using DNA 
methylation as a temporary method to alter gene expression as they move between 
high and low altitude. In chapter three we discussed the altitude associated differentially 
expressed gene dysferlin and how it has a variant (rs10166384) that may alter DNA 






balancing selection at site rs10166384 within dysferlin. This suggests that both the 
major and minor allele may both be beneficial among Andeans and Europeans residing 
at high altitude.    
In chapter two we found that the Native Andeans had higher placental gene 
expression values among genes associated with inflammation and Hofbauer cells 
compared to Europeans. This suggests that the Andeans are able to use the 
inflammation induced by the high altitude environment to recruit Hofbauer cells to 
induce angiogenesis, a phenomenon that has been shown to occur in vitro (241). The 
induced angiogenesis may lead to increase capillary surface area and better diffusion of 
nutrients across the placentas of high altitude Andeans.  Another potential mechanism 
that may contribute to increased angiogenesis and increased capillary growth is 
recruitment of maternal uterine natural killer cells (242). Uterine natural killer cells are 
attracted to sites of inflammation through secretion of chemokine CCL2 to induce 
angiogenesis resulting in capillary growth, a mechanism similar angiogenesis induced 
by Hofbauer cells (243). However, through our gene expression analysis we did not see 
differential expression of genetic markers associated with natural killer cells such as 
CD56 and CD16 (244, 245). Along with lack of differential gene expression, we found 
that gene expression microarray probes associated with CD56 and CD16 had low gene 
expression values. Low gene expression values suggests that little RNA from uterine 
natural killer cells was mixed with the placental RNA samples. One potential explanation 
for lack of differentially expressed natural killer cell markers is that during the sample 
processing the goal was to remove as much as the maternal tissue as possible to 






and washing off the maternal blood. Through removing maternal tissue we would have 
removed a majority of the uterine natural killer cells and any genetic markers associated 
with them.  
Due to the small sample size (n=45) we are only able to detect relatively large 
differences in gene expression so we focused on the most variable probes, which would 
likely have the greatest expression differences. It would be beneficial to increase the 
sample size to increase power. Along with increasing the power it would be useful to 
collect placentas from other populations with long-term inhabitance at high altitude such 
as those residing at the Tibetan plateau and the Ethiopian highlands. Prior work has 
looked at how the reduction in birth weight at high altitude changes across ancestral 
groups (122). Moore et al. found that those of Tibetan ancestry had less of a reduction 
in birth weight as they move between altitudes, compared to those of Han descent who 
reside at low altitude. Adapted individuals such as Tibetan and Andean individuals had 
birth weight reductions of 250g and 300 grams as they move from low altitude to high 
altitude respectively (~4000m).  This is different compared to non-adapted individuals 
including Europeans residing in Bolivian and Han Chinese residing in Beijing, China 
who have reductions in birth weight of roughly 450 grams and 500 grams respectively 
(122). If we were to compare differences in placental gene expression between 
individuals of Han and Tibetan descent and those of Andean and European descent, we 
would expect more differences between the Han and Tibetan individuals as the Tibetan 
individuals have resided at high altitude for more generations then those of Andean 






While decreased partial pressure of oxygen is one of the defining characteristics 
of the high altitude environment, there are other factors that contribute to the adverse 
environment. Individuals residing at high altitude also experience decreased air 
temperature, increased ultraviolet (UV) radiation and a less dramatic shift in seasonal 
weather compared to individuals residing at low altitude (247, 248). Residents residing 
at high altitude have developed cultural and physiological ways of adapting to the 
different factors affecting the high altitude environment. To adapt to the decreased 
temperatures, Andeans residing at high altitude have developed increase blood flow to 
the extremities to increase warmth and oxygen transport compared to Europeans 
residing at high altitude and individuals residing at low altitude regardless of ancestry 
(248). Also, residents at high altitude have darker skin found to be related to increased 
vascularity meaning the color change to blood flow is increasing skin reflectance 
compared to residents of low altitude (249).  The idea that adaptations to both 
decreased temperature and increased UV radiation may be related to increased blood 
flow suggests that increased blood flow in the placenta seen earlier in life may be 
similar to other physiological adaptions. 
In chapter three, we discussed how within the gene dysferlin (DYSF), there is a 
SNP (rs10166384) that has the ability to affect methylation at a transcription factor 
binding site for TEAD4. TEAD4 is a transcription factor that affects cell fusion and has 
been studied primarily in syncytial tissue, including skeletal muscle tissue and the 
formation of the syncytiotrophoblast (250). We predict that having the G allele at 
rs101066384 will lead to increased methylation within the TEAD4 transcription factor 






The reduced expression would lead to less efficient cytotrophoblast fusion in the 
placenta. Within C2C12 muscle cells, the lack of TEAD4 leads to shorter muscle cells, 
with 20% fewer nuclei compared to wild-type cells, similar to mouse primary myocytes 
when inhibited by short hairpin RNA targeting the TEAD4 transcription factor(235, 251). 
Also, those mice that lack the TEAD4 transcription factor show slowed skeletal muscle 
regeneration, a process similar to syncytiotrophoblast fusion (251, 252). Lastly in 
chapter 3 we focused on those individuals who gave birth without pregnancy 
complications and saw an increased A allele frequency in non-adapted individuals 
residing at high altitude. This leads us to predict that there would be a higher frequency 
of the G allele in those individuals who experienced pregnancy complications at high 
altitude. This would lead us to suggest rs10166384 as a potential marker for pregnancy 
complications at high altitude. 
Placental gene expression and other physiological responses to high altitude 
would also likely vary among species depending on the type of placenta that the 
individual animals have. For example, sheep have an epitheliochorial placenta, meaning 
that there is a layer of epithelial cells separating the maternal and fetal blood as well as 
a cotyledonary shape meaning that the placenta attaches to the uterine wall at many 
different points (253, 254). Parraguez et al. found that the there is more contact 
between the placenta and the uterine wall as evident through a 70 percent increase in 
cotyledon diameter in sheep residing at high altitude compared to those residing at low 
altitude with average cotyledon diameters of 2.70 cm and 1.59 cm respectively (255). 
This finding suggests that sheep born to the high altitude environment cope with the 






placenta and maternal uterine wall increasing the amount of exchange (255). Another 
animal used to study adaptation to high altitude is the yak (Bos grunniens). Qiu et al. 
compared the genome of the domestic yak to the genome of the domestic cow. They 
found positive selection in the yak in genes related to blood vessel size and regulation 
of angiogenesis suggesting that like in humans there are differences in angiogenesis 
and vascularization between the adapted yak species and the non-adapted domestic 
cow (256). An ideal animal that could be used as a non-human model organism to study 
adaptation to high altitude would be the guinea pig (Cavia porcellus). Like humans, 
guinea pigs have a hemochorial placenta which invades into the uterus more extensive 
then other rodents (257). Also, guinea pigs are native to the Andean altiplano making 
them good candidates to study high altitude adaption(258). Rockwell et al. noticed that 
guinea pigs born at high altitude weighed less then those born at low altitude with 
guinea pigs residing at high altitude having an average birth weight of 60.4 grams and 
those born at low altitude having an average birth weight of 74.5 grams (259). Also, 
studies have shown that guinea pigs are at greater risk of hypertension when pregnant 
at high altitude compared to non-pregnant individuals, with hypertension during 
pregnancy being a common symptom of preeclampsia in humans (260). 
In summary, this dissertation provides new information about how altitude effects 
gene expression and methylation in placentas of individuals of both European and 
Andean descent. It also provides evidence about how sequence variation effects DNA 
methylation as well in these same individuals. Because the placenta is an organ that 
mediates fetal growth, the adaptations we have described in the placenta may prevent 






evolutionary approach we have taken in these studies provides a framework for 
studying adaptations in human pregnancy. In the future it will be important to sample 
more individuals and more populations and gestational time points in order to gain a 
comprehensive few of placental adaptations. These present studies will also benefit 
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